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Abstract 
Phytoestrogens are plant-derived compounds that are structurally similar to the 
mammalian estrogen, 17(3-estradiol, and therefore are considered to play an important 
role in the prevention of menopausal symptoms, coronary heart disease, osteoporosis, 
and cancers. Isoflavones make up the most common form of phytoestrogens. They are 
found in a variety of plants, including fruits and vegetables, but they are 
predominantly found in leguminous plants and are especially abundant in soybean. 
Although the majority of studies on phytoestrogens have been conducted on soybean 
isoflavones, the isoflavones in other botanical species, such as red clover, kudzu, and 
ginseng, have drawn more and more attention due to their estrogenic-like properties. 
The present study was carried out further to characterize the isoflavone compounds in 
soybean and Gegen, the root of kudzu, and to study their hypocholesterolemic activity 
and possible adverse effects. 
The chemical compositions in soybean and Gegen isoflavone extracts were 
firstly determined. By using high performance liquid chromatography (HPLC), eight 
compounds were identified to be present in soybean isoflavone extracts namely 
daidzin, glycitin, genistin, 6"-0-malonyldaidzin, 6"-0-malonylglycitin, 
6"-0-malonylgenistin, daidzein, and genistein. Isoflavone components in Gegen were 
also identified, though some had not been confirmed, including 3"-hydroxy 1-puerarin, 
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puerarin, daidzin, genistin, daidzein, and genistein. 
The present study focused on the hypocholesterolemic activities of isoflavones 
derived from soybean and Gegen using hamsters of both genders as animal models. 
Female hamsters were ovariectomized and divided into four groups. They were all fed 
a 0.1% cholesterol diet either gavaged with water, soybean extract, Gegen extract, or 
given estradiol implant. It was found that the estrodiol group had the lowest levels of 
total cholesterol (TC), non high-density cholesterol (non-HDL-C), the ratio of 
non-HDL-C to HDL-C, and triglyceride (TG), and the highest ratio of HDL-C to TC 
among the four groups. Soybean supplement decreased TC, non-HDL-C, TG, and 
hepatic cholesterol effectively, while Gegen extract could greatly reduce the TC and 
hepatic cholesterol. 
Male hamsters were divided into castrated groups and intact groups fed a 0.1% 
high cholesterol diet. They were also gavaged with either water, or soybean extract, or 
Gegen extract. Soybean extract could decrease serum TC, non-HDL-C, and TG 
greatly in both castrated and intact male hamsters, while Gegen extract would change 
favorable almost the entire serum lipid profiles in castrated hamsters, but not in intact 
male hamsters. The results in female and male hamsters showed that the 
hypocholesterol-lowering effects of soybean and Gegen isoflavones might be 
attributable to their estrogenic-like activities and there might have sex specific and 
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treatment specific effects on serum lipid profiles. 
The present study also examined the possible adverse effects of isoflavones in 
soybean and Gegen on the development and reproductive system in weaned rats. The 
rats were daily gavaged with isoflavone extracts of soybean and Gegen with different 
dosages for three months. It was shown that both isoflavone extracts could inhibit the 
body weight gain with the increasing dosages, soybean isoflavones could decrease 
estradiol and progesterone levels in female rats, and testosterone concentration as well 
as sperm counts in male rats in a dose-dependent manner. While Gegen isoflavones 
had slight effects on sex hormone levels in both genders. It decreased sperm counts 
significantly in male rats given a high dose. 
In conclusion, isoflavones in soybean and Gegen may serve as health 
supplementation to modify the serum lipid profiles, however, the mega-dose should 
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Isoflavonoids are a unique subgroup of the flavonoids, one of the largest classes of 
plant phenolics with approximately 5000 member compounds. Isoflavonoids are found 
mainly in soybean and possess a chemical structure that is similar to 17p-estradiol, the 
most potent mammalian hormone estrogen (Wuttke et al., 2003). 
Isoflavones, one type of isoflanoids, are naturally occurring plant chemicals 
belonging to the "phytoestrogen" class that have been the focus of an exponential 
increase in the number of in vitro, in vivo, epidemiologic, and clinical research studies 
related to their health effects over the last two decades (Setchell, 1998). They are 
currently reported to use as potential alternative therapies for cancers, menopausal 
symptoms, cardiovascular disease and osteoporosis. 
1.2 Distribution and Origins 
Isoflavones have a relatively limited distribution in the plant kingdom. Flavones are 
found in many plant foods such as onions, apples, and grapes, whereas isoflavones occur 
primarily in the subfamily Papilionoideae of the Leguminosae. It is unknown why certain 
legumes contain isoflavones, whereas others do not. There are hundreds of isoflavones in 
legumes (Dewick, 1994). Kaufman et al (1997) reported the genistein and daidzein 
contents in vegetative parts of many legumes, including varieties such as psoralea 
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{Psoralea corylifolia), kudzu (Pueraria lobata), fava bean (Broad bean, Vicia faba), 
lupine (Lupinus leteus), soybean {Glycine max\ clover {Trifolium spp.), peas {Pisum 
sativum), chickpea {Cicer arietinum), mung bean {Phaseolus aureus) and lima bean 
(Phaseolus lunatus). Although isoflavones are present in various food legume seeds, the 
quantity in all except chickpea is very small as compared with that in soybean. In 
soybean, isoflavones exist in the entire plant, including the seeds, leaves, stems, seedlings, 
and roots. In soybean seeds, although the major quantity of the isoflavones is in the 
cotyledons, hypocotyls have a high concentration of isoflavones (Kudou et a!., 1991). 
Isoflavones occur predominantly as glycosides in plants and consequently are highly 
polar (water-soluble) compounds (Walz, 1931). Comprehensive analysis of the isoflavone 
contents of numerous soy foods has been reported, finding that most contain 0.1-3.0 mg/g 
of total isoflavones (Coward et ai, 1993; Murphy, 1982). 
1.3 History of Use 
Soybean is commonly used in Asian countries, such as China, Korea, Japan, and 
Indonesia. The bean itself cannot be eaten raw because it contains trypsin inhibitors that 
can disrupt digestion activities in the stomach, leading to cramping and discomfort 
(Tan-Wilson and Wilson, 1986). In Japan, soybean is sometimes boiled in very short time 
and then consumed readily as a snack. In China and many East Asian countries, soybean 
is processed to produce a protein-rich meat substitute (tofu). In Indonesia, soybean is 
fermented using a food-grade fungus of the Rhizopus species to produce another different 
protein-rich meat substitute called tempeh (Hachmeister and Fung, 1993). It is reported 
that the Japanese consume 25-100 mg of isoflavones per day (Coward et al” 1993). 
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Chinese women are estimated to consume 39 mg per day (Chen et al； 1999)，whereas the 
consumption of isoflavones in Western diets is much lower, at less than 1 mg per day in 
the United States and United Kingdom (De Kleijn et al., 2001; Safford et al., 2003). 
Another isoflavone-rich plant drawing more and more attention in recent time is 
kudzu. Kudzu is a deciduous liane, and is mainly distributed and used in mainland of 
China，Japan, and Korea. In China, it had been used not only as a folk medicine but also 
as a daily food from ancient time. In China and Japan Ko-fen flour, made from the kudzu 
roots, which we called Gegen, is used in soups. The entire plant can be used as drugs; 
stems are used for its antifebrile, antiphlogistic, and antidotal activities (Zheng et al., 
2002). Its flowers are used to counteract alcohol and also can relieve anorexia and vertigo, 
the leaves are detumescent and can stanch blood, its seeds can be used to treat diarrhea. 
Gegen is a good medicine to treat cold, dysentery, coronary heart disease, angina, 
hypertension, sudden deafness and neck tonus (Song, 1995). 
1.4 Chemical Structure 
Isoflavones are flavone variants in which the location of one of the phenolic rings is 
shifted. As diphenolic secondary metabolites, isoflavones are synthesized from products 
of the shikimic acid and malonyl pathways in the fusion of a phenyl-propanoid with three 
malonyl CoA residues (Taiz and Zeiger, 1998). 
The structural variations of isoflavones are numerous, depending on their 
substituents, oxidation levels and extra heterocyclic rings attached on the basic skeleton 
(Dewick, 1994). The main isoflavones of soybean are genistein and daidzein, and their 
respective glucosidic components are genistin and daidzin (Messina, 1999) (Fig 1.1). 
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Figure 1.1 Structures of genistein, daidzein, and estrogen (estradiol). 
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1.5 Physiologic Properties 
The isoflavones are strikingly similar in chemical structure to mammalian estrogens, 
17p-estradiol (Setchell and Adlercreutz, 1988). When the structures of the isoflavone 
metabolite equol and estradiol are overlaid, they can be virtually superimposed; the 
distance between the hydroxyl groups at each end of both molecules is virtually identical 
(Fig 1.2). It was found that the phenolic ring is a key structural element of most 
compounds that bind to estrogen receptors (ER) (Leclerq and Heuson, 1979). 
Isoflavones may act as both estrogen agonists and antagonists (Setchell and Cassidy, 
1999). The estrogenic effect of isoflavones is 10"^  to 10"^  times lower than that of 
estradiol (Messina, 1999). However, the concentrations of isoflavone in blood observed 
after regular consumption of soy products are 100 to 1000 fold higher than the 
endogenous estrogens concentrations (Tham et al., 1998). The physiologic effects of 
isoflavones may therefore be in part due to their estrogenic activity. On the other hand, by 
competing with endogenous estrogens for estrogenic receptors, isoflavones may also have 
antiestrogenic effects (Messina, 1999; Setchell, 1999). The effects of isoflavones are 
tissue specific owing to the presence of different types of estrogenic receptors ( a and yS) 
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Figure 1.2 Comparison of the structure of the isoflavone metabolite equol with that of 
estradiol showing the striking similarity in planar spatial arrangement of the two 
molecules. 
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1.6 Absorption and Metabolism 
The absorption, distribution, metabolism, and excretion (ADME) of isoflavones vary 
for subgroups in a population, based on age or gender, and among cultural groups (Gilani 
et ah, 2002). Additionally, differences in metabolic pathways may arise owing to different 
subpopulations of microflora, intestinal transit time, PH, or redox potential, factors that 
are influenced by diet, drugs (including antibiotics), bowel disease, surgery, and host 
immunity (Hendrich et al, 1999; Knight and Eden, 1995). 
The chemical form of isoflavones and its metabolites is an important consideration 
because it may influence the biological activity, the bioavailability, and therefore the 
physiologic effects of these dietary constituents, whereas structure itself is not a limiting 
factor for absorption from the gastrointestinal tract (Hendrich et al., 1999). Isoflavones 
normally occur as glucoside-bound moieties called glycones (Rao and Muralikrishna, 
2002; Peterson et al., 1998). However, it is the aglycone (glucoside-free) form of 
isoflavones that is metabolically active (Yuan et al., 2003). Some researches had 
discovered that intestinal microflora played a key role in the metabolism and 
bioavailability of isoflavones (Setchell et al, 1984). 
After consumption, the acetyl and malonyl derivatives of genistin and daidzin are 
metabolized to genistin and daidzin, which are then hydrolyzed by probiotic bacterial 
enzymes, the intestinal glucosidases, resulted in the removal of the glycoside moieties 
from the glycone form of isoflavonoids to produce the biologically active 
health-promoting aglycone isoflavonoids, daidzein, genistein and glycitein (Fig. 1.3). 
Aglycone phenolic compounds have been found to possess higher antioxidant activity 
and to absorb faster in the intestines than their glucoside-bound forms (Murota et al., 
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2002; Rao and Muralikrishna, 2002; Setchell et al, 2002). Those isoflavones that are not 
absorbed are excreted in the unconjugated form in feces (Adlercreutz et al., 1995). Once 
inside the blood stream, biologically active aglycone isoflavones travel to the liver, where 
they are converted into an inactive p-glucuronide, which is the predominant conjugate, 
representing up to 90 % of circulating isoflavones in both rats and humans (Holder et al., 
1999; Doerge et al., 2000). Cellular glucuronidases must remove the glucuronide moiety 
before isoflavones can exert its biological activity (Yuan et al, 2003). Alternatively, these 
aglycone compounds may be absorbed or further metabolized to many specific 
metabolites, daidzein and genistein, for example, may be metabolized to equol and 
p-ethylphenol, respectively (Joannou et al,, 1995; Kelly et al.’ 1993). The extent of 
metabolism appears to be highly variable among individuals and is influenced by other 
components of the diet (Setchell et al., 1984). 
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Figure 1.3 Scheme of the major biotransformation in the metabolism of isoflavones in 
human and animals. 
(Accepted from Kenneth et al., 1999) 
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1.6.1 Concentration of Isoflavones in Plasma 
When modest quantities of soy foods containing about 50 mg/d of total isoflavones 
were consumed, the plasma concentrations of daidzein, genistein, and equol in adults 
would achieve 50-800 ng/ml, which was similar to the plasma concentrations of Japanese 
consuming their traditional diet (Adlercreutz et al, 1993). 
The plasma half-life of daidzein and genistein, measured from their plasma 
appearance and disappearance curves, was 7.9 hours in adults; peak concentrations occur 
6-8 hours after administration of the pure compounds (Setchell, 1998). Consequently, 
adherence to a soy-containing diet will ultimately lead to high steady state plasma 
concentration. 
No attempts have been made to examine the concentrations of isoflavone glycosides 
in plasma after soybean ingestion, presumably because it is generally believed, although 
not proven, that intestinal hydrolysis of the glycoside is rapid and efficient (Setchell, 
1998). 
1.6.2 Urinary Excretion 
More recent studies have indicated that the extent of metabolic transformation of 
dietary isoflavones is more complex than originally thought (Kelly et al” 1993; Joannou 
et al., 1995). A detailed qualitative analysis of human urine revealed many other 
diphenolic metabolites that represent intermediates in the biotransformation of daidzein 
and genistein, many of which can only be successfully quantified by mass spectrometry. 
‘ K 
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Phytoestrogen concentrations in the urine and plasma of Japanese women 
consuming a traditional diet are high, as are those of vegetarians; the incidence of breast, 
endometrial and ovarian cancers in these groups is low (Adlercreutz et a/., 1991). 
1.7 Healthy Effects 
Isoflavones may have favorable estrogenic effects on the risk of cardiovascular 
disease (CVD) and are thought to be hypocholesterolemic, anticarcinogenic, 
antiproliferative, antiosteoporotic, and hormone altering. These health benefits may be 
attributable to a variety of potential mechanisms that are both estrogen receptor 
dependent and independent (Adlercreutz et al., 1995; Knight and Eden, 1996; Adlercreutz 
and Mazur, 1997). 
1.7.1 Menopausal Symptom 
Peri- and postmenopausal women often experience disruptive vasomotor symptoms 
(hot flush and night sweat) as a result of the drop in estrogen secretion that accompanies 
menopause. It is suggested that the frequency and severity of hot flushes is lower in 
Japanese than in Western women and that this could be due to their exposure to the high 
isoflavone intake from soy foods (Lock, 1991; Adlercreutz et al., 1991). 
The potential of using dietary estrogens as an alternative to estrogen replacement 
therapy (HRT) in the postmenopausal period to retard some of the symptoms and effects 
of estrogen loss is an area under active investigation. The hypothesis on phytoestrogens 
and menopausal symptoms is based on the fact that levels of estrogen are lower in 
- » 
11 
postmenopausal women; therefore, the phytoestrogens would have a better effect. 
Although most studies on phytoestrogens and menopause have been carried out in 
postmenopausal women, it could be that perimenopausal women would respond better 
due to their higher frequency of symptoms. It is also possible that women, whether peri-
or postmenopausal, would respond more to phytoestrogens if they had more symptoms to 
start with (Gilani and John, 2002). 
1.7.2 Cardiovascular Disease 
The effect of soybean intake on plasma lipids has been well known for a long time, 
but until last two decades it was thought that the phytoestrogens in soybean caused or at 
least contributed to this effect (Setchell, 1985). 
Though a variety of researches are compelling to help draw attention to the 
cholesterol-lowering effects of isoflavones, these data do not confirm conclusively that 
the effect is solely due to isoflavones. Nevertheless, there are other properties of 
isoflavones that are of benefit in reducing risk of cardiovascular disease. Isoflavones may 
slow the development of plaque formation by inhibiting cell adhesion and altering the 
activity of specific growth factors, such as platelet-derived growth factor and cytokines, 
which influence lesion formation (Rains and Ross, 1995). In addition, the antioxidant 
properties of isoflavones, though weaker than that of flavonoids, appear to have 




The continual loss of bone mass in the elderly is a natural process of aging. Women 
have a higher incidence of osteoporotic fractures than men due to their lower peak bone 
mass. In addition, the abrupt decrease in estrogen secretion in postmenopausal women 
accelerates bone loss (Tham et al, 1998). It was found two decades ago that the 
incidence of osteoporosis and the risk of hip fracture were significantly lower in 
postmenopausal Japanese women than in postmenopausal western women, possibly due 
to the phytoestrogens-rich soybeans and vegetables consumed in large quantities in 
Japanese diet (Cooper et al., 1992). 
The similarity in structure between the isoflavones and estrogen and the findings 
that isoflavones possess weak estrogenic properties shown in various experimental 
models provided the initial basis for speculation that isoflavones may promote bone 
health (Gilani and John, 2002). The possibility that phytoestrogens may offer a natural 
alternative to conventional HRT for the prevention of bone loss due to estrogen 
deficiency associated with loss of ovarian function during the menopause has led to a 
number of animal and clinical investigations of the effects of either soybean protein or 
genistein on bone remodeling (Setchell and Cassidy, 1999). The discovery of estrogen 
receptors in osteoblast cells and the importance of estrogen in down-regulating the 
activity of osteoclasts, thereby limiting bone resorption, are well recognized though the 
exact mechanism of the action is unclear (Komm et al, 1988). 
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1.7.4 Tumors 
It has been well established that cancer rates differ strikingly in various populations 
of the world. Hormone-related cancers of the breast, ovary, endometrium, and prostate 
have been reported to vary by as much as 5 to 20 fold between populations, and migrant 
studies indicate that the differential is largely attributable to environmental factors rather 
than genetics (Parkin, 1989; Ziegler et al.’ 1993). The highest rates of these cancers are 
typically observed in populations with Western lifestyles that include relatively high fat, 
meat-based, low fiber diets, whereas the lowest rates are typically observed in Asian 
populations with Eastern lifestyles that include plant-based diets with a high content of 
phytoestrogens (Parkin, 1989; Rose et aL’ 1986). 
The relationship between phytoestrogens and cancer is far from being clear, but the 
view is emerging that the anticancer effects are more likely to be due to a concerted 
action of many types of phenolic compounds including flavonoids, isoflavonoids and 
lignans than to single compounds. Furthermore, it seems that the beneficial anticancer 
effects may perhaps not be a result of an antiestrogenic effect via the estrogen receptor by 
blocking the action of more potent estrogens as originally believed, but to a number of 
other effects at many different levels such as hormone production, gonadotropin release, 
many steroid biosynthetic enzymes, and protein binding (Gilani and John, 2002). 
1' 7.4.1 Breast Cancer 
Interest in the relation between soy intake and cancer is due to the relatively low 
breast cancer mortality rates in Asian countries where soy foods are commonly consumed. 
In Japan, for example, the breast cancer mortality rate is only about one-quarter of that of 
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the United States (American Cancer Society, 1994). 
Animal studies using classic models of chemically induced breast cancer showed 
that a diet containing soy protein significantly reduced tumor formation and that this 
effect was lost when isoflavones were removed from the soy protein (Barnes et al., 1990). 
Critical studies of the effects of phytoestrogens on estrogen status and metabolism in 
premenopausal women remain to be undertaken, but the facts that dietary isoflavones can 
modulate endocrine status and influence ovarian cyclicity appear to be favorable with 
regard to potential breast cancer prevention (Setchell and Cassidy, 1999). 
入 7.4.2 Prostate Cancer 
As is the case for breast cancer, prostate cancer mortality rates vary markedly among 
countries. Analysis of the plasma and prostatic fluid from Asian men, who have a lower 
risk for prostate cancer relative to European men, found comparable higher 
concentrations of the isoflavones, equol and daidzein. Vegetarians or those consuming 
soy products in Western countries also have a lower risk of prostate cancer (Mills et al., 
1989; Adlercreutz, 1990). The results had consequently led to speculation that dietary 
phytoestrogens might play a role in the reduced risk for prostatic cancer that was evident 
from some epidemiologic studies (Morton et al, 1997). 
Genistein inhibits the growth of both androgen-dependent and 
androgen-independent prostate cancer cells in vitro (Perterson and Barnes, 1993; Naik et 
al., 1994). It is also reported that genistein may inhibit the metastatic potential of prostate 
cancer cells independent of cell growth inhibition, an effect that is associated with a 
decrease in the tyrosine phosphorylation of an unidentified molecular species (Santibanez 
• ft 
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e广 al.’ 1997). Although the precise role of estrogen in prostate cancer is not well clarified, 
the potential estrogenic effects of isoflavones may be protective because estrogens have 
been used successfully as a form of hormone therapy for metastatic prostate cancer 
(Pienta et al, 1993). 
1.7.5 Alcohol Addiction 
In a series of researches, daidzin and daidzein were isolated from Gegen, the root of 
the kudzu plant, which is an herb used in Chinese medicine to treat alcohol addiction, and 
found to be potent inhibitors of human mitochondrial aldehyde dehydrogenase (ALDH-2) 
and alcohol dehydrogenase (yy-ADH) (Keung, 1993; Keung and Vallee, 1993; Xie et a!., 
1994). Studies showed that intraperitoneal daidzin in ethanol-preferring Golden Syrian 
hamsters suppressed the desire for alcohol; therefore it may be proposed that these 
isoflavones might be useful in the treatment of alcohol abuse (Keung and Vallee, 1993). 
Subsequent studies in rats showed that daidzin administration lowered and delayed peak 
blood alcohol concentrations compared with the control animals, but there was no effect 
on the activities of hepatic alcohol dehydrogenase or aldehyde dehydrogenase activities 
(Xie et al.’ 1994). 
1.7.6 Potential Adverse Effects 
In recent years, products containing phytoestrogens derived from flaxseed, red 
clover, and soybean have begun to be increasingly marketed and consumed for potential 
health benefits by many segments of the population, including women of childbearing 
16 
age. In addition, over the past several decades, a substantial number of infants have 
consumed soy infant formula as their major source of nutrition, because many 
manifestations of toxicity resulting from developmental exposure may not be evident 
until later in life, the safety assessment of these agents after exposure during 
developmental stages in an issue of considerable importance (Gilani and John, 2002). 
The health risk assessment of isoflavones is complicated because of many factors. 
For example, most studies were performed using soy-based foods as a source of 
isoflavones and not pure chemicals. Soy-based foods contain a large number of 
biologically active substances in addition to isoflavones, which makes it difficult to 
interpret the studies because the results observed may be due to the activity of these other 
substances and not isoflavones, and the other substances may increase or decrease 
isoflavone activity (Setchell, 1998; Burow et al.，2000). 
1.8 Summary 
There is insufficient evidence to recommend that the public increase the intake of 
isoflavones to treat or prevent disease. Therefore, further study is required to confirm the 
beneficial effects of isoflavones on disease processes. 
In humans, the suggestion of adverse effects of dietary isoflavones has been based 
on observations from animal studies. The concerns are countered by a long history of safe 
use in all subpopulation. Existing epidemiologic and observational studies of isoflavones 
do not indicate adverse reproductive effects in humans, and evidence to support the 
hypothesis that soy consumption has not been identified (Ian et al.，2003). While the 
putative dangers are greater when it is considered how easily a dietary dose of 
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isoflavones can be achieved. Therefore, this pharmacologic aspect of supplements is a 
concern and requires further investigation to establish safe levels of consumption (Gilani 
and John, 2002). 
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Chapter 2 
Determination of Isoflavones in Soybean and Gegen 
2.1 Introduction 
2.1.1 Classification and Structure of Phytoestrogens 
Phytoestrogens encompass several classes of compounds including flavonoids, 
isoflavones, coumestans (coumestrol), and lignans (Fig. 2.1). These phytochemicals 
belong to a larger class of polyphenols and are found in some plants; they are 
characterized by having nonsterpidal structures similar to mammalian estrogens, such as 
17p-estradiol, and having estrogenic properties. With a few exceptions, the presence of a 
phenolic ring is an essential feature in the chemical structure of phytoestrogens and is a 
prerequisite for binding to estrogen receptors (ER). Therefore, phytoestrogens can act 
either as estrogen agonists or as estrogen antagonists (Kurzer et al” 1997). Hormone-like 
bisphenolic phytoestrogens, isoflavonoids (daidzein and genistein), coumestans 
(counestrol), and lignans are of great interest because of their antiestrogenic, 
anticarcinogenic, antiviral, antifungal, and antioxidant activities as well as their 
estrogenic properties (Price et al” 1985; Cheng et al, 1954). 
Isoflavones represent a group of distinct secondary metabolites, which are produced 
predominantly in leguminous plants (Yu et al., 2000). The synthesis of isoflavones in 
plants is based on a carbon skeleton of 3-phenylbenzpyrone and on different oxidations of 
the three central atoms. The isoflavone structure differs in the degree of methylation, 





Isoflavonoids Lignans Others 
Isoflavones Coumestans 
Figure 2.1 Classifications of the major sources of dietary phytoestrogens. 
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2.1.2 Isoflavones in Soybeans and Gegen 
Most of the flavonoids are ubiquitous in the plant kingdom, but the isoflavones are 
restricted primarily to one plant family, the Leguminosae (Fabaceae) and occur only 
rarely in other families, such as the Apocynaceae, Pinaceae, Compositae, and Moraceae 
(Tahara et al., 1995). In the present study, the interest was focused on the isoflavone 
concentration in soybean and Gegen. 
Soybeans and soy foods provide the most abundant dietary sources of isoflavones 
(Kurzer et al., 1997). Soybeans contain about 1.2-3.3 mg of isoflavones / g dry weight 
(Wang et al., 1994). It was well known that a lower incidence of cancers compared with 
the Western world has been observed in Far Eastern populations that consume large 
amounts of soy products, for example, in Japan the average consumption of isoflavones 
was 25-100 mg per day (Coward et al.’ 1993). This has been attributed to a greater 
consumption of soy foods in those countries. Gegen was traditionally used in China, 
Korea, and Japan as a medicine or as a diaphoretic and febrifuge or as a supplementation 
in soup. 
There are 12 known isoflavone compounds in soybeans (three aglycones, three 
glucosides, three acetyl-acetyl-ester glucosides, and three malonyl-ester glucosides). 
Among them, 6"- O 一 malonylgenistin, genistin, 6"-0-malonyldaidzin, and genistin are 
the major constituents (Fig. 2.2 and Fig.2.3). In nonfermented soy foods, the isoflavones 
are mainly in the form of glucoside conjugates, whereas in fermented soy foods (e.g., 
miso and tempeh), the aglycones are common (wang et al., 1994). 
Total concentrations of genistein and daidzein (on a dry weight basis) vary in soy 
products, such as alcohol-extracted soy protein concentrate and soy protein isolate (SPI), 
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having genistein and daidzein lowered than in whole soybean. In general, isoflavones are 
lost not during the defatting of full-fat soybeans, but during the SPI processing steps, 
previous study reported that 19%, 14%, and 22% are lost during extraction, precipitation, 
and washing, respectively (Bakke et al., 1956). Unprocessed soybeans contain 1.2-3.3 mg 
of isoflavones / g dry weight, whereas high-protein soy ingredients such as soy flour and 
texturized vegetable protein (TVP) contain 1.1-1.4 mg/g dry weight. Soy concentrate, 
which is produced by water or alcohol wash of soy flakes to remove soluble 
carbohydrates and improve functionality, contains an extremely low isoflavones 
concentration (John et al., 1998). 
There are 15 known isoflavone compounds in Gegen (Kudzu root, root of Pueraria 
lobata). Daidzein, daidzin, puerarin and puerarin-O-xyloside are reported to be the major 
constituents (Song, 1995) (Fig. 2.4). Table 2.1 shows the concentrations of isoflavones in 
soybean and Gegen. The data show that the isoflavone levels in soybean are higher in 
genistein but lower in daidzein than those of Gegen. 
Table 2.1 Isoflavone Contents of Soybean and Gegen. 
Daidzein Genistein 
Description Reference 
(mg/lOOg dry weight) 
Soybean (Glycine max) 11-85 27-103 Mazur et al, 1998 
Gegen (Pueraria lobata) 185 13 Mazur et aL, 1998 
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R2 O k ^ p 
R 1 R 2 R 3 
Daidzein H H OH 
Genistein H OH OH 
Glycitein 0CH3 • H OH 
Formononetin H H 0CH3 
BiochaninA H OH 0CH3 
Figure 2.2 A representative structure of the three major isoflavones aglycones (daidzein, 
genistein, and glycitein) and the 4-methyl ether derivatives of daidzein and genistein, 
formononetin and biochanin A in soybean. 
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Daidzin H H OH 
Genistin H OH OH 
Glycitin 0CH3 H OH 
6"-0-Acetyldaidzin H H C0CH3 
6"-0-Acetylgenistin H OH C0CH3 
6"-0-Acetylglycitin 0CH3 H C0CH3 
6"-0-Malonyldaidzin H H COCH2CH3 
6"-0-Malonylgenistin H OH COCH2CH3 
6"-0-Malonylglycitin 0CH3 H COCH2CH3 
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Daidzein H H H H H 
Daidzin H glc H H H 
Puerarin H H glc H H 
Puerarin-O-xyloside H OH glc H H 
3"-Hydroxylpuerarin H H glc OH H 
3"-Methoxypuerarin H H glc OMe H 
Daidzein 8-C-Apiosyl-( 1 -6)glucoside H H glc + 6api H H 
Genistein 8-C-Apiosyl-( 1 -6)glucoside OH H glc •> 6api H H 
Genistein OH H H H H 
Formononetin H H H H Me 
Daidzein 4",7-diglucoside H glc H H glc 
Puerarin-xyloside H H glc ^ 6xyl H H 
Genistin OH glc H H H 
Genistein 8-C-glucoside OH H glc H H 
Puerarin 4"-0-glucoside H H glc H glc 
Figure 2.4 Structure of isoflavones in Gegen 
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2.1.3 Methods of Determination 
2.1.3.1 Isolation and Purification of Isoflavones 
Isoflavones are present in soybeans as both simple (aglycones) and conjugated 
(glucoside) form. It is apparent that the profile of isoflavones could be altered not only 
during the commercial processing of the soybeans but also during extraction. Therefore, 
the accuracy of identification and quantification of isoflavones present in soybeans and 
their products are highly dependent upon the extraction/purification procedures and 
conditions used in each method. Solvent, the ratio of material to solvent, extracting time 
and temperature are reported to be the influence factors on extraction and purification 
(Wang and He, 2002). 
2.1.3.2 Analytical Methods for Isoflavones in Soybeans and Gegen 
A wide range of analytical techniques has been applied for determination of 
polyphenols and phytoestrogens in foods and biological materials. The analytical 
methods for determining phytoestrogens consist mainly of high-performance liquid 
chromatography (HPLC) with a photodiode array (PDA), electrochemical, fluorometric, 
or mass spectrometric (MS) detector (Wang et al” 1994) or gas chromatography (GC) 
with an MS detector (Tekel et aL, 1999; Mazur et al., 1998; Adlercreutz et al., 1997). 
While HPLC with different detectors is more commonly used to determine 
phytoestrogens compared with GC analysis (Adlercreutz et aL’ 1997). Thomas et al. 
(2001) developed a method using HPLC-UV with a detection limit of about 2 ng / ml for 
daidzein, genistein, and glycitein. HPLC with PDA/UV detection (using reverse-phase 
CI8 column) has been a method of choice to determine phytoestrogens in soy foods for 
• « 
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many years and is currently the most widely used analytical technique to quantify 
isoflavones (Wang et al., 1994) and coumestrol (Lookhart, 1979). It is particularly 
suitable for pharmacokinetic studies and has numerous advantages, such as ability to 
measure both free and nonconjugated molecules, the combined "free and conjugated 
molecules", and the total free and conjugated molecules in foods, plasma, and urine. 
Nowadays, more simple and rapid procedure has been developed to determine 
isoflavonoids and their conjugates in foods by extraction, hydrolysis, and HPLC analysis 








2.3 Materials and Methods 
2.3.1 Extraction and Isolation of Soybean and Gegen Isoflavone Extracts 
Dried soybean and Gegen powders (3 kg) were extracted with 18 liters of 70% 
ethanol three times at 70 ° C, respectively. In each portion, ethanol was evaporated 
under vacuum in a rotary evaporator to yield about 1550 g of ethanol extract, which was 
then dissolved in 2 liters of distilled water. The ethanol extracts were then partitioned 
with chloroform in a ratio of 1:1 for three times. The chloroform fractions were 
discarded and the remaining ethanol/HiO fractions were saved for HPLC analysis as 
described below. 
2.3.2 HPLC Analysis 
2.3,2.1 Sample Preparation for the HPLC Analysis 
All wet samples extracted as described in 2.3.1 were freeze-dried before the HPLC 
analysis. One gram of dried, finely ground samples was placed in a 100 mL conical 
flask containing 40 mL of methanol, 20 mL of 0.1 N HCl and 0.2 mL of flavone (11.25 
mM in methanol). The mixture was sonicated for 10 minutes and then stirred at room 
temperature for 2 hours using a magnetic stirrer. Extractants were centrifliged at 850 g 
for 10 minutes. The supernatant of sample was filtered through a 0.45 |xm PTEE filter 
[poly (tetrafluoroethylene), Alltech Associates Inc., Deerfield, IL, USA]. The 
supernatant was transferred into a 1.5 mL sample vial (Hewlett Packard, Palo Alto, CA, 
USA) and then subjected to HPLC analysis. 
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2.3.2.2 HPLC Analysis 
All the isoflavones and their glycosides were analyzed using a Shimadzu HPLC 
equipped with a ternary pump delivery system and a diode array detector (G1946A). 
In brief, 10 |LI1 of the supernatant was loaded onto a CI 8 column (Hypersil ODS, 4.6 
X 250 mm, 5 ^iM, Alltech, Deerfield, USA) via a rheodyne valve (20 capacity, Cotati, 
CA). The diode array detector was set from 200 to 400 nm, and the eluting components 
were monitored at 260 nm. The analysis for determination of the isoflavones and their 
glycosides were carried out according to the method of Wang and Murphy (1994) with 
some modifications. The mobile phase consisted of 1% acetic acid in water (v/v) 
(solvent A) and acetonitrile (solvent B). After injection of the sample, solvent B was 
increased from 10 to 20% in 40 min and then increased from 20 to 100% in the next 30 
min. The flow rate was maintained at 0.8 mL/ min. The typical HPLC chromatogram 
of soybean was shown in Figure 2.5 and Figure 2.6. 
2.3.3.3 Qualitative Analysis of the Isoflavones and Their Glycosides in Soybean and 
Gegen 
The isoflavones and their glycosides were determined by comparing the retention 
time with those of authentic standards by the method as described in part 2.3.3.2. 
Authentic standards for genistein, glycitein and daidzein with purity higher than 98% 
were obtained from Sigma Chemical Company (St. Louis, MO, USA). Flavone was used 
as an internal standard. 
All of the standards for Gegen were provided by the Institute of Material Medical, 
Chinese Academy of Medical Sciences, Peking Union Medical College. 
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2.4 Results 
2.4.1 Isoflavone Identification of Soybean Extract 
The eight compounds were identified by studying their various retention time (Table 
2.2 and Fig. 2.5). The results were compared with those obtained from Barnes et al. 
(1994) and the authentic standards of various isoflavones and their glucosides in soybean 
extracts. 
Table 2.2 Isoflavone compounds of soybean extracts. 
Compound Name Retention Time Concentration (%) 
Compound 1 Daidzin 19.634 10.0213 
Compound 2 Glycitin 21.815 2.8397 
Compound 3 Genistin 31.731 14.2465 
Compound 4 6"-0-malonyldaidzin 36.124 9.6143 
Compound 5 6"-0-malonylglycitin 38.172 1.9964 
Compound 6 6"-0-malonylgenistin 49.040 16.8483 
Compound 7 Daidzein 50.651 0.0699 
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2.4.2 Isoflavone Identification of Gegen Extract 
The compounds of Gegen were identified by studying their various retention time 
(Table 2.3 and Fig. 2.6). The results were compared with those obtained from Barnes et al. 
(1994) and the authentic standards of various isoflavones. 
Table 2.3 Isoflavone compounds of Gegen Extracts. 
Compound Name Retention Time Concentration (%) 
Compound 1 3'-hydroxyl-puerarin 11.893 0.3422 
Compound 2 Unknown 13.287 0.2463 
Compound 3 Puerarin 17.792 51.119 
Compound 4 Unknown 20.637 4.4635 
Compound 5 Daidzin 25.892 8.829 
Compound 6 Unknown 28.798 2.2188 
Compound 7 Unknown 30.139 3.4613 
Compound 8 Unknown 34.071 0.9782 
Compound 9 Genistin 38.807 1.4206 
Compound 10 Unknown 43.002 1.0475 
Compound 11 Unknown 51.084 0.3416 
Compound 12 Daidzein 52.678 1.2201 
Compound 13 Unknown 55.282 1.1024 
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2.5 Discussion 
The principal phytoestrogen isoflavones known are daidzein (4”， 
7-dihydroxyisoflavone) and genistein (4”，5, 7-trihydroxyisoflavone). It is believed that 
all isoflavones are derived from a restricted number of simple isoflavone aglycones, such 
as daidzein and genistein (Fristsche et al., 1999). In addition, a minor component of 
isoflavones, glycitein (4", 7-dihydroxy-6-methoxyisoflavone or 6"-methoxydaidzein), has 
been isolated from plants, but no estrogenic activity has been reported to date for this 
compound (John et al., 1998). 
The major difference between flavones and isoflavones is in their basic skeleton 
structures. Flavones contain a 2-phynylchroman, whereas isoflavones contain a 
3-phenylchroman. The structural variations of isoflavones are numerous, depending on 
their substituents, oxidation levels and extra heterocyclic rings attached on the basic 
skeleton (Dewick, 1994). The most commonly studied 12 forms in soy are genistein, 
daidzein, and glycitein and their glycosides, 6"-0-acetyl and 6’，-0-malonyl glucosides. 
Aside from these 12 forms, succinyl glucosides of genistein, daidzein and glycitein also 
have been reported (Kanaoka et al.’ 1998). There are also two methylated derivatives of 
genistein and daidzein, which are formononetin and biochanin A in clover, garbanzo and 
alfalfa, respectively. 
The major components in Gegen are purarin, daidzein, daidzin, glycitin, genistin and 
genistein. Zeng et al. (1999) reported that pueraria stems and roots are similar in 
chemical structure, so pueraria stem as a potential resource could be used as a substitute 
for pueraria roots. 
Wang and He (2002) studied four factors: extracting time, temperature, content of 
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alcohol in extracting solvent, and the ratio of material to solvent in extracting Gegen 
isoflavones. The result showed that temperature had much effect on the extraction of 
Gegen isoflavones, and 70°C was proper temperature for extraction, which was the 
temperature adopted in the present study for extraction. The content of alcohol in 
extracting solvent had little effect on the extraction. 
Flavone was adopted in the HPLC analysis as an internal standard in many previous 
studies, but flavone might increase the analytical time (John et al., 1998). There were 
certain losses during the multistep extraction of isoflavones, and an internal standard 
should be used for precise isoflavone quantification. An ideal internal standard should be 
a compound structurally related tp the analytes and with a similar polarity but with a 
retention time that does not overlap the other peaks in the chromatograph. In this regard, 
flavone was chosen as an internal standard in the present study. 
Glucosides, the simple malonyl and acetyl forms of isoflavones can be hydrolyzed 
by acid treatment. In the present study, 0.1 N HCL was used to hydrolyze glycosidic 
isoflavones. Wang et al. (1990) compared hydrolysis of glucosides under three 
concentrations, using 1, 2，and 3 N HCL solution, at 98-100°C for various periods of 
times. Conversion of glucosides to aglycone by acid treatment was the best at 1 N HCL 
for 2 hours. A higher concentration of acid than 1 N HCL would decrease the aglycone 
content beyond 2 hours of hydrolysis. Daidzein was found to be more stable than 
genistein against boiling acid treatment. Alkaline treatment at a high temperature caused 
the breakdown of the malonyl or acetyl ester linkages. 
Coward et al, (1993) reported that Asian and American soy products, with the 
exception of alcohol-washed soy protein concentrate and isolates, had total isoflavone 
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contents including aglycones and glucosides forms, similar to those of the whole soybean. 
Wang and Murphy (1996) reported the loss of isoflavones during the manufacturing the 
tempeh, soy milk and tofu, and protein isolate. Soaking and heating in the tempeh 
production caused loss of 12% and 49% of total isoflavone, respectively. Only 24% of 
the isoflavones were retained in the final tempeh product. From processing soybean to 
soy milk, there was not a significant loss of isoflavones. However, from processing 




Hypocholesterolemic Effects of Soybean and Gegen 
Isoflavone Extracts in Ovariectomized, Intact Male and 
Castrated Golden Syrian Hamsters 
3.1 Introduction 
Cardiovascular disease (CVD) is a leading cause of death for both men and women 
in Western countries. Some of the primary modifiable risk factors for atherosclerosis and 
cardiovascular disease include dislipidemia [e.g., elevated low density lipoprotein (LDL) 
cholesterol, elevated plasma triglycerides, reduced high density lipoprotein (HDL) 
cholesterol concentration] and elevated blood pressure. It was reported that 
approximately 40-50% of American ^ 2 0 y old have LDL cholesterol concentrations > 
130 mg/dl, a level that is associated with higher coronary heart disease (CHD) risk 
(American Heart Association, 2002). Whereas the mortality rates from CHD among the 
Chinese and Japanese populations are among the lowest in the world and dietary factors 
could play a role (International Diabetes Federation, 2001). 
Menopause is defined by the Council of Affiliated Menopause Societies (CAMS) of 
the International Menopause Society as the permanent cessation of menstruation resulting 
from the loss of ovarian follicular activity (International Menopause Society). 
Menopausal, whether natural or surgical, is associated with elevations in circulating total 
and LDL cholesterol and reduction in HDL cholesterol concentrations, placing 
postmenopausal women at greater risk for CHD (Bruschi et al.，1996; Fukami et al., 1995' 
- “ 38 
Goldstein et al., 1995; Sullivan, 1996). This increased risk is believed to be due to 
changes in lipoprotein metabolism that accompany the loss of endogenous estrogen 
secretion (Nasr et al； 1998). Estrogen replacement therapy (ERT) reduces the risk of 
CHD in part through the modulation of serum cholesterol (Godsland et al., 1987; Knight 
et al., 1996). However, ERT and other cholesterol-lowering pharmacological agents may 
be accompanied by side effects (U.S. Department of Health and Human Services, 1993) 
and therefore are recommended only for women without known contraindications. 
A large body of epidemiological data suggests an inverse relationship between the 
consumption of soybean isoflavones and CVD risk. The incidence of cardiovascular 
CVD and other chronic diseases is. much lower in Asian, which is associated to a higher 
consumption of soy-based products than in Western countries (Tham et al.’ 1998). 
Interest in the potential role of isoflavones as an important hypocholesterolemic agent in 
soybean has been raised as a result of their estrogenic potential (Potter, 1995; Anthony et 
al., 1996; Balmir et al” 1996). Isoflavones are one of the major classes of phytoestrogens 
that have been the focus of an exponential increase in the number of in vitro, in vivo, 
epidemiologic, and clinical research studies related to their health effects over the last two 
decades (Setchell, 1998). Isoflavones have structural similarities with estrogen, which has 
hypocholesterolemic properties (Bierman et al, 1992, Stampfer et al., 1985). 
Whether isoflavones are the principle physiologically active component responsible 
for the cardioprotective benefit of soy is a subject of considerable debate (Tikkanen et al” 
2000). The evidence does not fully support the hypothesis that isoflavones per se, 
separated from soy protein, could reduce blood lipids, although this unresolved issue 
could be related to the fact that different diets may contain different total amounts as well 
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as different ratios of the 12 known isoflavones，i.e., individual isoflavones could differ in 
biological potency and certain combinations could also have different physiologic effects 
(Friedman et al,2m\). 
Current studies on isoflavones are mainly focused on soybean and its extracts, and 
there are very rare reports of Gegen, the root of Pueraria bolata Ohwi or Pueraria 
thomsonii Benth.，which has been used as food and drug in Asian areas from ancient time. 
In fact, isoflavone concentration in Gegen is much higher than that of soybean. Gegen 
has long been used in clinical application as vasodilator, anticoagulant, and antioxidant, 
and mainly studied in the treatment of alcohol abuse. Only recently, puerarin, daidzein, 
genistein, the major components in Gegen isoflavones, has drawn attention for their 
estrogenic like activity and in prevention of bone loss in ovariectomized rats, but the 
hypocholesterolemic activities of them has not been clearly studied. 
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3.2 Objective 
A previous study in this laboratory showed ovariectomization increased blood 
cholesterol, and soybean isoflavones suppressed ovariectomization-induced rise in blood 
cholesterol in Golden Syrian hamsters. The present study was carried out further to 
investigate the hypocholesterolemic activity of soy-derived isoflavones and 
Gegen-derived isoflavones in not only ovariectomized, but also castrated hamsters fed a 
high cholesterol diet. 
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3.3 Materials and Methods 
3.3.1 Preparation of Soybean and Gegen Isoflavone Extracts 
Soybean and Gegen extracts were prepared as previously described in Chapter 2 
(2.3.1.1) with some modification. In brief, dried soybean and Gegen powders (3 kg) 
were extracted with 18 liters of 70% ethanol three times at 60°C. Ethanol was 
evaporated under vacuum in a rotary evaporator. The extracts were then dissolved in 2 
liters of distilled water and partitioned with chloroform in a ratio of 1:1 for three times. 
The chloroform was removed and the remaining aqueous solution containing the 
isoflavones was freeze-dried and re-dissolved into 100 mL of water. The isoflavones of 
soybean and Gegen were determined as previously described in Chapter 2 (2.3.2.3). 
3.3.2 Animals and Diets 
Golden Syrian hamsters of both genders (n = 102; 37 females, 3 mo, 160-170 g; and 
65 males, 2 mo, 140�150 g) were housed in same-sex groups (2-3 hamsters per cage) in 
an animal room at 2 5 � C with 12:12-h light-dark cycles. The animals were given free 
access to a standard cereal-based chow diet (PicoLab® Rodent Diet20-Lab Diet, 
Australia) for 10 days. 
All the female hamsters were ovariectomized and waited for seven-day recovery 
from the operation before the experiment started. They were all allowed free access to a 
0.1% cholesterol diet (Glen Forrest Stockfeeds, Western Australia, Australia) and tap 
water (Table 3.1). The ovariectomized hamsters were randomly divided into four 
groups (n=9~10 each group). The first group was the control group, while the second 
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group had the time-releasing estradiol-17P subcutaneous (pellet) implants (21 days) 
(Sigma chemical, St. Louis, MO, USA) as a positive control. The third group was orally 
administered with soybean extract (30 mg isoflavones / kg body weight) per day, and the 
fourth group administered with Gegen extract (30 mg isoflavones / kg body weight) per 
day. 
Similarly, male hamsters were maintained on a 0.1% cholesterol diet and allowed 
free access to tap water. Twenty-six male hamsters were castrated while eight male 
hamsters were treated as a sham group. After seven-day recovery, the castrated hamsters 
were randomly divided into three groups. The first group was the control receiving orally 
distilled water while the second and third group were orally given either a single dose of 
soybean isoflavone extracts (30 mg isoflavones / kg body weight) or Gegen isoflavone 
extracts supplement (30 mg isoflavones / kg body weight) respectively. 
Additional thirty-one male hamsters were randomly divided into four groups. One 
group was fed a standard cereal-based diet as a negative control, the other three groups 
was fed the 0.1% cholesterol diet and given orally either distilled water (positive control) 
or soybean or Gegen isoflavone extracts (30 mg isoflavones / kg body weight). 
The body weight of all the hamsters was recorded once a week, and food 
consumption was recorded every 2 or 3 days. At the end of 6 weeks, all the hamsters were 
sacrificed after overnight fasting. Blood was collected via the abdominal aorta. After 
clotting, the blood was centrifuged at 3000 rpm for 10 minutes and serum was then 
collected. The liver, heart and kidney were also removed, rinsed with ice-cold saline, 
weighted and stored at —80 °C for determination of cholesterol content. 
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Table 3.1 Composition of High Fat Diet plus 0.1% Cholesterol for Hamsters 




Crude Fiber 4.5 
Calcium 0.75 
Phosphorus 0.7 
Digestible energy is 15.5 MJ per kg of diet; diet has added lard at an addition rate of 
lOOg/kg and cholesterol at a rate of Ig/kg; diet was free of mammalian products. 
(Adapted from Glen Forrest Stockfeeders) 
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3.3.3 Serum Lipid and Lipoprotein Determinations 
Serum TG and TC levels were determined using enzymatic kits (Sigma Chemical, St. 
Louis, MO, USA). The concentration of HDL-C was measured after precipitation of 
LDL and VLDL with phosphotungstic acid and magnesium chloride, using a commercial 
kit (Sigma). Non-HDL cholesterol was calculated as the difference between TC and 
HDL-C. 
3.3.4 Determination of Cholesterol Concentration in the Organs 
The liver (100 mg), kidney (300 mg) and heart (300 mg) were used to determine the 
cholesterol level. In brief, the tissue sample and 1 mg stigmastanol, as an internal 
standard, were homogenized in 15 mL chloroform-methanol (2:1, v/v) and 3 mL saline. 
The chloroform-methanol phase was removed and dried down under a gentle nitrogen 
steam. After 1 hour mild hydrolysis with 5 mL of 1 N NaOH in 90% ethanol at 90 °C, 
1 mL of water and 6 mL of cyclohexane were added for extraction of cholesterol The 
cyclohexane phase was evaporated to dryness under nitrogen, and cholesterol was 
converted to its TMS-ether derivative by a commercial TMS-reagent (dry 
pyridine-hexamethyldisilazane- trichlorosilane, 9: 3: 1，v/v/v, Sil-A regent, Sigma). 
After 1 hour at 60�C，the mixture was removed under a gentle stream of nitrogen. The 
TMS-ether derivative was dissolved in 600 |LIL of hexane, and after centrifugation, the 
hexane phase was transferred to a vial for gas-liquid chromatograph (GLC) analysis. 
The TMS-ether derivative was analyzed in a fused silica capillary column (SAC™-5, 30 
m X 0.25 mm, i.d.; Supelco, Inc., Bellefonte, PA, USA) in a Shimadzu GC-14B GLC 
ft 
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equipped with a flame-ionization detector (Shimadzu, Kyoto, Japan). The column 
temperature was set at 285°C and maintained for 20 minutes. Helium was used as 
carrier gas at a head pressure of 22 psi. A typical GLC chromatogram of liver 
cholesterol is shown in Figure 3.1. 
3.3.5 Statistics 
Data are expressed as mean 土 standard deviation (SD). The group means were 
statistically analyzed using one-way analysis of variance (ANOVA) on SigmaStat 
Advisory Statistical Software (S i^aSta t version 11.0，SPSS Inc., Chicago, IL, USA). 
P-value less than 0.05 are regarded statistically significant. 
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Figure 3.1 GLC Chromatographic Profile of Cholesterol in the Liver 
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3.4 Results 
3.4.1 Food Intake and Body and Relative Organ Weights 
Food intake was expressed as the diet each hamster consumed each day, while food 
efficiency ratio was defined as the body weight gained by each hamster that consumed 
every 100 grams of diet. Relative organ weights were expressed as grams of organ 
weights per 100 gram of body weight. 
Daily food consumption did not differ among the experimental groups in 
ovariectomized hamsters (Table 3.2). Subcutaneous estradiol implants, and oral 
administration of soybean and Gegen isoflavone extracts could cause significant 
decreased food efficiency ratio in ovariectomized hamsters. The final mean body weights 
of the groups received estradiol implants and orally administered with Gegen isoflavone 
extracts decreased significantly compared with those of the control group and the group 
orally administered with soybean isoflavone extracts (Table 3.2，Fig 3.1). A decreased 
relative liver weight and increased relative kidney and heart weights were caused by 
estradiol treatment compared with other groups, whereas no difference in relative weights 
of liver, kidney and heart was observed between the control and the groups orally 
administered with soybean and Gegen isoflavone extracts. 
No difference was seen in food consumption and food efficiency ratio among the 
four groups in intact male hamsters, and they also had similar initial and final mean body 
weights among the four experimental groups (Table 3.3, Fig 3.2). High cholesterol diet 
resulted in higher relative liver weights than those in the group fed normal diet, while 
soybean extracts could significantly attenuate the effects in the intact male hamsters. 
Similarly, no difference was observed in food consumption and food efficiency in 
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castrated hamsters fed a high cholesterol diet (Table 3.4). The group administered with 
Gegen isoflavone extracts in castrated hamsters had higher final average body weight 
than that of the other groups (Fig 3.3). Oral administration of soybean and Gegen extracts 
had no effect on the relative liver, heart and kidney weights compared with control group 
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Figure 3.1 Changes in body weight of ovariectomized hamsters fed a high cholesterol diet 
with subcutaneous estradiol Implant treatment or oral administration of 30 mg soybean 
and Gegen isoflavones per kg body weight, respectively. Data were expressed as mean 土 
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Figure 3.2 Changes in body weight of male hamsters fed a normal cereal-based diet or 
high cholesterol diet with oral administration of 30 mg soybean or Gegen isoflavones per 
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Figure 3.3 Changes in body weight of sham and castrated hamsters fed a high cholesterol 
diet with oral administration of 30 mg soybean or Gegen isoflavones per kg body weight. 
Data were expressed as mean ± SD, n = 8-9. 
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3.4.2 Effects of Soybean and Gegen Isoflavone Extracts on Serum and Organ 
Cholesterol in Ovariectomized and Intact Male and Castrated Hamsters. 
Effects of soybean and Gegen extracts on blood cholesterol were examined in 
ovariectomized hamsters. Serum TC, non-HDL cholesterol and triglyceride 
concentrations in the groups received subcutaneous estradiol implant and oral 
administration of soybean isoflavone extracts tended to be significantly lower than those 
of the control group in ovariectomized female hamsters (Table 3.5). Serum TC was also 
dramatically reduced by Gegen isoflavone extracts, with both non-HDL cholesterol and 
triglyceride were slightly lowered compared with the control group. The HDL cholesterol 
concentration was not changed by any of the treatments, while estradiol treatment could 
increase the ratio of HDL to TC and decrease the ratio of non-HDL-C to HDL-C 
significantly, although both soybean and Gegen isoflavone extracts also had these effects, 
the differences between the control and the administered groups were not statistically 
significant. Hepatic cholesterol level could be affected slightly among the three treatment 
groups compared with the control group in ovariectomized hamsters, while soybean 
isoflavone extracts could decrease the cholesterol level in heart dramatically, and 
estradiol treatment would greatly reduce cholesterol concentration in kidney. 
Effects of soybean and Gegen extracts on blood cholesterol were also examined in 
the intact male hamsters (Table 3.6). Oral administration of soybean isoflavone extracts 
would statistically reduce TC, non-HDL, the ratio of non-HDL to HDL, and TG 
concentration compared with the control group. Although HDL could only be increased 
slightly, the ratio of HDL to TC would be greatly elevated by soybean isoflavones. Gegen 
isoflavones had all of the effects as soybean isoflavones, but the difference was not 
� “ 56 
significant compared with the control. Cholesterol levels in liver, heart, and kidney was 
not statistically lowered by soybean isoflavones, while Gegen isoflavones could only 
increase the cholesterol levels in heart. 
Administration of soybean isoflavone extracts significantly decreased serum TC, 
non-HDL-C, and TG in castrated hamsters compared with the control castrated hamsters 
(Table 3.7). Gegen isoflavones significantly reduced non-HDL, the ratio of non-HDL to 
HDL and TG, and increased HDL and the ratio of HDL to TC. Hepatic cholesterol level 
was dramatically reduced by soybean isoflavones, while the cholesterol concentration in 
kidney was greatly decreased by Gegen isoflavones. 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Golden Syrian hamsters were chosen to use as an animal model because they 
have responses similarly as humans with respect to effect of dietary cholesterol on 
blood lipids and the development of atherosclerotic lesions. As in humans, male and 
female hamsters differ in plasma lipid concentrations and atherosclerosis 
susceptibility (Nistor et al., 1987; Robins et al, 1995; Wilson et al,, 1999). Male 
hamsters fed moderately atherogenic diets have elevated plasma concentrations of TG, 
TC and increased atherosclerosis. However, female hamsters fed these diets, like 
women; do not exhibit plasma lipid elevations and atherosclerosis (Robins et aL, 1995; 
Wilson et al, 1999). Both ovariectomized hamsters and surgically or naturally 
postmenopausal women develop elevated serum total and non-HDL cholesterol 
concentrations and lose their protection from atherosclerosis (Robins et al., 1995; 
Bruschi et aL, 1996). 
The present results demonstrated that supplementation of soybean and Gegen 
isoflavones with 30 mg / kg BW for only 6 weeks was effective in lowering serum TC 
in moderately hypercholesterolemic ovariectomized hamsters similar to that received 
estradiol implants. Soybean and Gegen isoflavones could also significantly reduce the 
non-HDL-C level, suggesting they possess the similar estrogenic like activity in 
, modifying lipid profile. Estrogen may affect the metabolism of apolipoproteins, which 
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are constituents of HDL and LDL (Deeley et al., 1985). The majority of cholesterol in 
blood circulates is in LDL and HDL particles. Epidemiologic observations and 
clinical trials have consistently documented a positive relation between LDL 
cholesterol concentrations and cardiovascular disease risk and a negative relation 
between HDL cholesterol concentrations and CVD risk (Stein et al,’ 1999). 
Observational data suggest that the ratios of HDL-C to TC and non-HDL-C to HDL-C 
are better predictors of subsequent cardiovascular disease than individual lipid 
concentration, especially in the presence of increased TG (Castelil et al, 1983; 
Wakatsuki et al., 1995). In the present study, these ratios could be statistically 
modified by estradiol treatment, but effects of both soybean and Gegen isoflavones on 
these ratios were insignificant. Although the results of hamsters cannot be transfer 
thoroughly to those of humans, it suggested the effects of isoflavones derived from 
soybean and Gegen to modulate blood lipids and to prevent cardiovascular disease in 
postmenopausal women. 
Soybean isoflavones could help significantly reduce TG, similar to that of 
estradiol, while Gegen isoflavones slightly but insignificantly lowered level of TG in 
ovariectomized hamsters. The results were inconsistent with the report of Zheng et al. 
(2002), who showed that estradiol increased TG level of ovariectomized SD rats in 
the early time of treatment, and had no effects in the late period, while TG could be 
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greatly decreased by Gegen isoflavones in the early time, and the effect would 
attenuate gradually. This discrepancy suggested the hypocholesterolemic effects of 
Gegen isoflavones were attributed not only by its estrogenic like property, but also by 
other unexplored mechanism. It was noted the decrease in plasma TG levels was 
associated with a decrease in the food efficiency ratio and body weight gain in the 
treatment groups compared with the control group in ovariectomized hamsters. This 
suggests that isoflavones, like estrogen, affect energy balance in ovariectomized 
hamsters. 
The liver plays a major role in maintaining whole body cholesterol homeostasis, i. 
e., it is the major site for elimination of cholesterol from the body via bile, either 
through conversion of cholesterol into bile acids or direct biliary cholesterol secretion. 
The liver also produces VLDL, and is a major catabolic site for LDL through the LDL 
receptor-mediated pathway (Spady et al, 1983; Spady and Dietschy, 1985). In the 
present study on ovariectomized hamsters, hepatic cholesterol level decreased slightly 
by soybean and Gegen isoflavones, and significantly increased by the estradiol 
implant compared with the control. The increase in ratio of HDL to TC might imply 
that estradiol accelerate the reversal cholesterol transport from the peripheral parts of 
the body back to the liver for degradation. 
There appear to be no clear gender differences in the bioavailability or 
I ri 
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metabolism of isoflavones, and therefore many of the potential benefits attributed to 
dietary isoflavones are probably applicable to men. It was reported that ovarian 
hormones presumably modulate the protection of female hamsters from 
hyperlipoproteinemia and atherosclerosis because ovariectomized hamsters would 
lose that protection (Robins et al, 1995), while whether the susceptibility of the male 
hamsters to elevated plasma lipid concentrations and atherosclerosis is dependent on 
testicular-derived androgens was not known. 
Soybean isoflavones supplementation could modify favorably almost all of the 
serum lipid parameters in male hamsters, but it only decreased serum TC without 
changing the ratios of HDL-C to TC and non-HDL to HDL in ovariectomized and 
castrated hamsters. In ovariectomized hamsters, Gegen isoflavones could only 
decrease the serum TC level, however, Gegen isoflavone did not change serum TC, 
but it could significantly modify the non-HDL, ratios of HDL to TC and non-HDL to 
HDL, and TG levels in castrated hamsters. The data suggested the 
hypocholesterolemic effect of the soybean isoflavone extracts was different from that 
of Gegen isoflavone extracts. There might have sex specific and treatment specific 
effects on lipid profiles in hamsters between the two isoflavones. 
It is known that soybean products possess cholesterol-lowering activity. However, 
the active ingredients responsible for its hypolipidemic activity remain controversial. 
• x 
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Several researchers have claimed that the cholesterolemic lowering effect of soybean 
extracts is not attributed to the protein portion but to isoflavones (Anthony et al., 1996; 
Anthony et al.’ 1997; Kirk et al., 1998). In contrast, others have claimed that 
cholesterol-lowering activity of soybean is due to the interaction of protein with other 
components such as isoflavones (Lucas et al, 2001; Greaves et al, 1999; Greaves et 
al., 2000; Tovar-Palacio et al, 1998). In several studies, soy protein, treated with 
alcohol to remove isoflavones, showed no cholesterol-lowering effect in animals 
(Anthony et al., 1996; Anthony et al, 1997; Kirk et al.’ 1998), whereas other studies 
have found the hypocholesterolemic effect of soy protein is not modified after the 
alcohol extraction (Balmir et al, 1996; Jenkin et al.’ 2002; Sanders et al, 2002). The 
present study found that soybean isoflavones were effective in reducing cholesterol 
not only in male hamsters but also in castrated and ovariectomized hamsters, 
suggesting that isoflavones are at least one of the components in soybean responsible 
for its hypocholesterolemic activity. 
Previous studies seldom studied effect of the isoflavones derived from different 
plants on blood cholesterol level. The present study found that not only soybean but 
also Gegen isoflavones could regulate favorably the lipid profile in ovariectomized 
hamsters. The data on different genders and treated hamsters, although could not be 
directly transfer to humans, suggested that administration of isoflavones of soybean 
H 
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and Gegen might be an effective way in lowering serum cholesterol level and 
modifying lipid profiles in postmenopausal women. Due to the difference in types and 
concentration of isoflavones, soybean and Gegen may exert sex-specific and 




Possible Developmental and Reproductive Toxicity of 
Soybean Isoflavones in SD Rats 
4.1 Introduction 
An increasing number of environmental and industrial compounds have been 
identified as endocrine-active, and exposure to these compounds raises a major health 
concern (Barlow et al., 1999). Due to the widespread presence of endocrine-active 
compounds (EACs) in the environments, humans and animals may be exposed to 
various combinations of them under many circumstances. Among the classes of EAC 
drawing particular interest are the phytoestrogens, which are plant-derived chemical 
agents with estrogen-like activity commonly found in the diets of humans, wildlife, 
and experimental animals. The biological actions of the phytoestrogens are believed 
to have health implications to the populations that regularly consume them, while 
their existence in diets for experimental animals has also raised questions about their 
overconsumption (Brown and Setchell, 2001). 
For centuries, soybean has been a regular part of the diet in many countries. 
Hence, those populations have long consumed isoflavones, naturally occurring 
phytoestrogen components of soybean, in substantial quantities where soybean intake 
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is high. There has been no indication of risk to human health when soybean or 
soybean isoflavones are consumed as a regular part of the diet. Furthermore, 
epidemiological studies over the last decades have suggested protective effects of 
these compounds against a number of chronic diseases, including coronary heart 
disease and breast, endometrial, and prostate cancers. However, nowadays a variety of 
soybean supplements, with high concentration of soybean isoflavones, are consumed 
as a trend for health promotion all over the world, because isoflavones possess 
estrogenic activity, a number of detrimental effects have been postulated, as well as 
mechanisms by which such effects may be mediated (Ian et al., 2003). 
There has been considerable research on the possible effects of soybean 
isoflavones on reproductive function and developmental growth in men and pre-, peri-, 
and postmenopausal women because of the structural similarity to endogenous 
estrogen, 17 目-estradiol. There has been a concern that the apparent decline in sperm 
quality over recent decades (Irvine, 1999) might be related to increased exposure to 
environmental endocrine disrupters (Carlsen et al” 1992; Sharpe and Skakkebaek, 
1993). In addition, human intervention trials with phytoestrogen-based supplements in 
pre- and post- menopausal women have indicated estrogenic actions, which may be 
adverse to health. 
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The influence of phytoestrogens on the development of male infants is also one 
of the concerns. Furthermore, other adverse effects may also arise from the estrogenic 
properties of these compounds. There have recently been some concerns relating to 
the estrogens used in the oral contraceptive pill and hormone replacement therapy and 
a possible increase in the risk of deep vein thrombosis (formation of blood clots) 
(Helen, 1997). 
Controversy thus exists as to whether soy-based infant formulas containing 
isoflavones pose a health risk, especially to male infants, and should be avoided. The 
influence of a high phytoestrogen intake on reproductive hormone concentrations in 
infants, and whether any alterations could result in disruption of the imprinting of 
subsequent sexual behaviors, are the questions that needs further investigation (Irvine 
et al.’ 1996). 
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4.2 Objective 
This study investigated whether and how exposure of neonatal rats to soybean 
isoflavones altered pubertal reproductive development and other growth parameters. 
* f4 
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4.3 Materials and Methods 
4.3.1 Diet 
All rats were fed a standard cereal-based chow diet (PicoLab® Rodent Diet 20 -
Lab Diet, Australia). The nutritional value of the diet was shown in Table 4.1. 
Soybean isoflavone extract of 65% purity was purchased from ZheJiang Xinxin 
Bio-Tech Co. LTD (Zhejiang, China), containing 21.08% daidzin, 2.27% glycitin, 
33.44% genistein, 4.28% daidzein, 0.95% glysitein, and 1.79% genistein. The major 
compounds of soybean isoflavone extract were verified using HPLC as described in 
chapter 2 (2.3.2) and shown in Figure 4.1. 
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Table 4.1 Composition of the chow diet 
Nutrients Percentage (g/lOOg) 
Crude Protein not less than 20.0 
Crude Fat (Ether extract) not less than 4.5 
Crude Fiber not less than 6.0 
Nitrogen-Free Extract (by difference) 54.8 




Sprague-Dawley rats of 50 females and 50 males (21 days of age) were housed 
(5 rats per cage) in an animal room at 25 °C with 12:12-h light-dark cycles. 
4.3.3 Study Design 
At weaning (i.e. 21 days of age), SD rats of both genders were sexed. After a 
quarantine period of 7 days, the rats were weighted and allocated to one of the five 
treatment groups, having the approximately equal group mean body weight (n = 10 
per group). The four experimental groups were gavaged with 30,150, 300, 600 mg 
soybean isoflavones / kg body weight / day, while the control group was gavaged with 
the same volume of water. The rats were fed ad libitum for 3 months from weaning 
(day 1 of the study) until the day of sacrifice (3 months of the study). Food 
consumption and body weight of each cage were recorded twice a week. 
The change trends of reproductive hormones during the experiment period were 
also evaluated by measuring the serum hormone levels at the 6出 week and the end of 
the study using radioimmunoassay (RIA) (DPC Inc. Los Angeles, USA). Estradiol 
and progesterone levels were quantified in female rats, while testosterone level was 
analyzed in male rats. 
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After 3 months of feeding, all of the rats were sacrificed; blood was collected via 
the abdominal aorta, organs were dissected and weighted, both blood and organs were 
stored at -80°C for further analysis. 
4.3.4 Measurement of Reproductive Hormones 
Estradiol, progesterone and testosterone were tested by coat-A-count 
radioimmunoassay. The Coat-A-Count hormone procedure was a solid-phase 
radioimmunoassay, wherein ^^^I-labeled reproductive hormone competed for a fixed 
time with target hormone in the sample for antibody sites. Because the antibody was 
immobilized to the wall of a polypropylene tube, simply decanting the supernatant 
suffices to terminate the competition and to isolate the antibody-bound fraction of the 
radiolabeled hormones. Counting the tube in a gamma counter then yielded a number, 
which converted by way of a calibration curve to a measure of the target reproductive 
‘ hormone present in the serum. 
4.3.5 Measurement of Sperm Number 
Because matured sperms were mainly stored in epididymis head, the epididymis 
head was cut, weighted and minced in saline, then filtered and diluted. An aliquot of 
* H 
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the epididymal sperm suspension was used for spermatozoa count using a 
hemocytometer. Smears were prepared on glass slides and observed under a 
microscope. 
4.3.6 Statistics 
Data were expressed as Mean 土 Standard Deviation (SD). The group means were 
statistically analyzed using one-way analysis of variance (ANOVA) on SigmaStat 
Advisory Statistical Software (SigmaStat version 10.0，SPSS Inc., Chicago, IL, USA). 
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4.4.1. Food Intake and Food Efficiency Ratio 
Food consumption and food efficiency ratio was measured as previously defined 
in chapter 3 (3.4.1). There was a slight increasing trend of food consumption and a 
reduced trend in food efficiency ratio with the increasing dosages of soybean 
isoflavones in female rats. There was no difference in food consumption among the 
five groups in male rats, while food efficiency ratio showed a significant decreasing 






































































































































































































































































4.4.2 Growth Trend 
There were significant differences in body weight gain among the 5 groups of 
female rats. In general, no significant differences in body weight gain were observed 
among the middle and high doses groups (150mg, 300mg and 600mg isoflavones/kg 
BW)，however, the body weight gain in the three groups with 150mg, 300mg and 
600mg isoflavones/kg BW were smaller compared with that of the control and 30 mg 
isoflavones / kg BW group (Table 4.3 and Fig 4.2). 
In male rats, growth depression was first seen in the dose group of 600 mg 
isoflavones/kg BW; this change reached statistical significance at week 3 of study 
compared with the control group. At the week 4，dose groups with 150 and 300 mg 
isoflavones began to show statistical retardation in body weight gain compared with 
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Figure 4.2 Changes in body weight of rats fed the chow diet with oral administration 
of 0，30, 150，300, 600 mg soybean isoflavones per kg body weight. Data were 
expressed as mean 土 SD, n = 10. 
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4.4.3 Organ Weight 
4,43,1 Absolute Organ Weight 
There were statistically significant increases in absolute liver weight observed in 
dose groups of 300 and 600 mg isoflavones/kg BW compared with the control group 
in female rats. Other changes, such as decreases in absolute heart, kidney, spleen and 
uterus weights, were seen in the dose groups of 150, 300，600 mg soybean 
isoflavones/kg BW in comparison with the control group (Table 4.4). 
Similar changes were observed in male rats. Oral administration of 300 or 600 
mg soybean isoflavones was associated with significantly smaller absolute weights of 
heart, spleen, and prostate. No difference in weights of kidney, testis, and epididymis 
was observed between the control and the four groups orally administered with 
soybean isoflavones (Table 4.4). 
tt 
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Table 4.4 Absolute organ weight (g) in rats fed the chow diet with oral administration 
of 0，30，150, 300，600 mg soybean isoflavones per kg body weight. 
Soybean Isoflavones (mg/kg body weight) 
Control 30 150 300 600 
Female 
Heart 0.80±0.07ac 0.82 土 0.05a o.74±0.10b 0.79 土 0.75 土 0.04^ 
Kidney 1.95 土 0.12a 2.03 ±0.25' 1.72 土 0.15b 1.89 土 0.19a 1.89 土 0.12a 
Liver 8.26 土 0.59� 8.44 土 0.90bc 8.66 土 0.94*^� 9.28 ± 1.19b 10.52 土 1.47" 
Spleen 0.39±0.03ab 0.38±0.04ab 0.36 土 0.04b o.41 土 0.04a 036 土 0.05b 
Uterus 0.51 土 0.06a 0.54 土 0.09a Q44 土 • 06b 0.50 土 0.38 土 0.06� 
Ovary 0.07 ±0.03 0.08 ±0.02 0.09 ±0.02 0.09 土 0.01 0.09 土 0.02 
Male 
Heart 1.45 土 0.09a 136 土 o.08b 1.36 土 0.08b 132 土 o.lO^ 1.24 土 0.10� 
Kidney 3.39 土 0.39 3.49 土 0.18 3.28 土 0.26 3.25 土 0.32 3.33 土 0.27 
Liver 15.49 土 1.83a 15.49 土 1.69a 15.04 ± 1.80ab 13.9I 土 1.32b 14.32 土 0.64ab 
Spleen 0.74 土 0.1 r 0.77 土 0.1 r 0.73 土 0.08a 0.6O 土 0.06b 0.57 土 0.07b 
Testis 3.30 土 0.23 3.20 土 0.15 3.33 土 0.13 3.29 ±0.26 3.29 土 0.20 
Prostate 0.69 土 O.lOa 0.73 土 0.12a o.71 土 O.lia 0.58 土 0.09b 0.52 土 0.13b 
Epididymis 1.26 ±0.10 1.26 土 0.12 1.27 土 0.12 1.22 土 0.13 1.20 土 0.09 
Seminal Vesicle 0.59 土 0.09 0.55 土 0.08 0.56 土 0.08 0.52 土 0.05 0.51 ± 0.10 
Data were expressed as mean 士 SD, n = 10; Means at the same raw with different 
superscript letters (a, b, c) differ significantly a tP < 0.05. 
83 
4,4,3,2 Relative Organ Weight 
Oral administration of 300 and 600 mg soybean isoflavones led to a smaller body 
weight gain compared with the control. Therefore it would be better to express the 
organ weight as relative organ weight instead. The determination of relative organ 
weight was as previously described in chapter 3 (3.4.1). 
The female rats with administration of 150, 300, 600 mg isoflavones had a 
greater relative liver weight compared with the control. Oral administration of 600 mg 
soybean isoflavones had no effect on the relative heart weight but it would increase 
the relative weight in ovary and decrease that of the uterus (Table 4.5). 
The relative weight of kidney, liver, testis, and epididymis significantly increased 
in the groups orally given 300 and 600 mg isoflavones/kg BW in male rats (Table 4.5), 
while no change was seen in the relative weights of heart and prostate. 
• n 
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Table 4.5 Relative organ weight (organ weight (g)/100 g body weight) in rats fed the 
chow diet with oral administration of 0，30，150，300，600 mg soybean isoflavones per 
kg body weight. 
Soybean Isoflavones (mg/kg body weight) 
Control 30 150 300 600 
Female 
Heart 0.32 ±0.02 0.32 土 0.03 0.31 ±0.02 0.32 ±0.03 0.32 土 0.03 
Kidney 0.77±0.05ab 0.79 土 0.74 土 0.03b 0.77 土 0.07ab 0.81 ± 0.07a 
Liver 3.26 土 0.23� 3.28 土 0.22� 3.66 土 3.77 土 0.37b 4.42 ± 0.22a 
Spleen 0.1与土 0.02ab 0.15 土 O.OOb 0.15 ± 0.0 严 0.17 土 0.02a 0.15 土 
Uterus 0.20土0.03a o.21 土0.03" 0.19土0.03ab 0.21 土0.02a o . l6±0 .03b 
Ovary 0.03 土 O.Olb 0.03 土 0.04 土 O.Oiab 0.04 土 O.Oiab 0.04 土 O.Oia 
Male 
Heart 0.29 ±0.02" 0.27 土 O.Olb o.29 土 0.30 土 0.02a 0.3O 土 0.02a 
Kidney 0.66 土 0 . 0 6 � 0 . 6 9 土 0.03bc 0.68 ±0.02。 0.73 土 0.05b 0.8I 土 0.05& 
Liver 3.04土 0.27b 3.05 土0.22b 3.10土0.2lb 3.19 土0.28b 3.52 土 
Spleen 0.14 土 0.02ab 0.15 土 O-Opb 0.15 土 0.02a o . l3± 0.02b 0.14±0.02ab 
Testis 0.65 土 0.06bc 0.61 ±0.04� 0.69 土 0.05b o.76 土 0.08a o.80± 0.06a 
Prostate 0.14 土 0.02 0.14 土 0.03 0.15 土 0.02 0.13 土 0.02 0.13 土 0.03 
Epididymis 0.25 土 0.02" 0.24 土 0.02b o.26±0.03& 0.28 土 0 .038�o.29± 0.02a 
Seminal Vesicle 0.12 土 0.11 土 0.02b o.l l 土 0.0产 0.12 土 0.02ab 0.12 ± 0.02a 
Data were expressed as mean 土 SD，n = 10; Means at the same raw with different 
superscript letters (a, b, c) differ significantly a t P < 0.05. 
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4.4.4 Reproductive Hormone Levels 
There was no significant difference in reproductive hormones among the five 
groups in female rats at week 6 of study, while at the end of the experiment; both 
estradiol and progesterone were statistically decreased in the groups orally 
administered with 150, 300, and 600 mg isoflavones/kg BW. At week 6 of the study, 
the testosterone was lowered in the groups on 300 and 600 mg isoflavones/kg BW in 









































































































































































































































































































































4.4.5 Epididymis Parameters of Male Rats 
Epididymis length was observed significantly shorter and sperm number was 












































































































































































































































Phytoestrogens have been reported to cause infertility in animals and human 
infants if consumed in a large quantity. Phytoestrogens, when fed at relatively high 
doses, have been shown to cause changes in reproductive tract, resulting in 
developmental abnormalities in rodents (Hughes, 1998; Benetau-Pelissero et al., 2001; 
Setchell et al” 1987; Cassidy et al” 1994). Although the mechanism remains unclear, 
they may be considered as potential endocrine disrupters, and therefore it should be 
cautious when taking them at a large quantity. Some concerns have been discussed 
about the risks associated with phytoestrogens such as increased plasma concentration 
of isoflavones in babies that ingest soymilk, the ability of non-hormonal secondary 
plant metabolites to modify sex steroid metabolism, and the effects of phytoestrogens 
on thyroid development (Ibarreta et al., 2001). 
One of concerns on soybean isoflavones is their possible adverse effect on sexual 
maturation of infants receiving very high levels of isoflavones in soy-based infant 
formula (Setchell et aL, 1997; Mendez et al., 2002). This is particular important for 
baby boys, who normally exhibit luteinizing hormone (LH) secretion between birth 
and 6 months of age (Sharpe et aL, 2002). It is therefore important to note that 
beneficial effects of isoflavones on the development of cancer through the inhibition 
. of certain enzymes have been observed at levels that are all much higher (some>20 
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times higher) than those observed normally in human plasma (Le Bail et al., 1998; 
Fotsis et al” 1998; Evans et al.，1995). At these levels, isoflavones may have 
antiandrogenic effects, influence male and female fertility and sexual development in 
utero and after birth, and induce testicular atrophy (Levy et aL, 1995; Nagao et al； 
2001; Delclos et al., 2001; Wisniewski et al., 2003). 
The present study examined the effects of different concentrations of soybean 
isoflavone extracts on a variety of estrogen-dependent tissues in rats. The present 
results confirmed the role of soybeans as a source of compounds with estrogen-like 
activity. Indication of toxicity of the soybean isoflavone extract may be found in the 
growth suppression seen in rats administered with relatively higher doses (150, 300 
and 600 mg isoflavones / kg body weight). Since food consumption would not be 
affected with the increasing doses, the effect of body weight retardation might be 
partially accounted for by the decrease in food efficiency ratio observed in the same 
groups of rats, which was ascribed to the mal-digestion and mal-absorption. However, 
the inhibitory effects of phytoestrogens on the growth of rodents were reported due to 
the suppression of growth hormone secretion by the anterior pituitary (Hartsook and 
Magruder, 1957; Stob’ 1983). Evidence of toxicity of the soybean extracts was also 
reflected from the increased relative liver weight in both genders. The results 
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demonstrated that high dose of soybean isoflavones intake might have hepatotoxicity, 
and then could induce liver tumefaction, resulting in malfunction of liver. 
The present study found that soybean isoflavones at high dose affected 
development of uterus and ovary in female rats. These effects were primarily 
characterized by decreasing the relative uterus weight (uterus atrophic effect) and 
increasing the relative ovary weight. The atrophic effect to the uterus might induce 
mal-function of uterus and result in a series of chain reaction. The present results were 
in disagreement with that of study reported by Gallo et al., (1999) who demonstrated 
that 2.4% soy supplemented to standard diet could cause an increase in relative 
uterine weight (uterotrophic effect) and this change was indicated by Stob (1983) as 
one of the best known estrogenic responses when exogenous estrogens were 
administered to animals and they served as the basis of bioassays for the detection of 
estrogenic activity of feed. The discrepancy of the results may due to the different 
dose and mode given to the rats. The high dose adapted in the present study was much 
higher than that applied in the study of Gallo et al. (1999)，the response in this study 
may indicate the antiestrogenic effect of soybean isoflavones instead. Furthermore, 
variability in species as well as strain in response to compounds with estrogenic 
activity is well documented (Adams, 1989). The amount of soybean isoflavones 
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absorbed from the gut is currently unknown. All of these variables could account for 
the different results. 
In addition, another recent report was also supporting the possibility of the 
adverse effect of soybean isoflavones on postnatal sexual development in a group of 
immature, ovariectomized Sprague-Dawley rats that ingested a commercially 
available, closed-formula diet containing "high amounts" of genistein and daidzein 
(stated to be “21 mg genistein and 14 mg daidzein per lOOg of rat feed"), and failed to 
exhibit a uterotrophic response to administered estradiol. This finding suggested that 
the response was already stimulated to nearly maximal levels by phytoestrogens 
before the animals were treated with estradiol (Boettger-Tong et al” 1998). However, 
in another study involving immature, intact Sprague-Dawley females exposed to even 
higher doses of genistein (37.5 or 75 mg per 100 g body weight of diet), no detectable 
increase in uterine weight was observed when compared to the controls fed the same 
diet (Sntell et al., 1997). This result implied that, at lease with respect to this assay, 
intact females were much less responsive than ovariectomized females to dietary 
phytoestrogens. The results of both reports might explain the decreased level of uterus 
weights in rats orally given high dose of soybean isoflavones in the present study. 
Estradiol concentration in female rats orally administered with high dose of 
soybean isoflavones showed a decreased level, suggesting the anti-estrogenic effect of 
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soybean isoflavones. High doses of soybean isoflavones have been shown to inhibit 
progesterone synthesis when tested in cultures of bovine granulose cells (Kaplanski et 
aL, 1981)，and such an inhibition of progesterone production could be a plausible 
explanation for the decrease of progesterone level in rats administered with high dose 
of soybean isoflavone extracts in the present study. 
In mature females, follicle-stimulating hormone (FSH) initiates the growth and 
development of ovarian follicles, and accompanies LH, to caiise ovulation and steroid 
(estrogen and progesterone) production. Circulating levels of FSH and LH are both 
controlled by a negative feedback effect on the hypothalamus by the steroid hormones 
(Lerchl, 2001). Due to the lack of a negative feedback mechanism, with diminished 
estradiol and progesterone, the circulating FSH and LH levels become significantly 
increased which may induce ovarian failure and then result in infertility. 
Potential adverse effect on male rat development might be associated with high 
dose of soybean isoflavone consumption. The increased relative testis weight was 
observed in soybean isoflavones treated male rats, this could account, at least partially, 
for the action of phytoestrogens. Testosterone was suppressed significantly in the four 
groups orally administered with soybean isoflavones. In the male, testosterone is 
mainly synthesized in the interstitial Leydig cells and the testis, and is regulated by 
the interstitial cell stimulating hormone (ICSH), or LH of the anterior pituitary (the 
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female equivalent of ICSH). Testosterone is also a key player in spermatogenesis at 
puberty (Sharpe, 1994). The present study demonstrated that neonatal exposure to 
high dose of soybean isoflavones could reduce testosterone levels in blood in early 
puberty and such a change might persist into adulthood. 
Testosterone, a classic endocrine factor, is also the best-documented local 
regulator of spermatogenesis and acts both as an endocrine and local (paracrine and 
autocrine) factor within testis. In the mature male, FSH is associated with the 
stimulation and maintenance of spermatogenesis. Testosterone and estradiol have the 
role of providing the negative feedback mechanism to the hypothalamus for 
controlling the release of FSH. Testicular failure may be functional failure to mature 
or a result of germ cell damage. Whatever the etiology, the conditions of 
hypogonadism have the net result of dramatically raising the circulating FSH levels, 
due to the lack of a negative feedback mechanism. Since LH stimulates testosterone 
synthesis, it is indicated that both LH / testosterone and FSH are necessary for 
qualitatively and quantitatively normal development of spermatogenesis at puberty 
(Weinbauer et al., 2001; Cooper and Yeung, 2001). The decreased level of 
testosterone observed in the treated male rats from the present study might be a 
plausible explanation to the low levels of sperm numbers in the same rats. The results 
were consistent with the report that coumestrol consumption by rat pups suppressed 
• u 
95 
testicular testosterone concentrations and resulted in abnormal sexual behavior in 
adulthood (Whitten and Naftolin, 1992). 
The data observed in the present study suggested that long-term exposure to high 
doses of soybean isoflavones could produce significant suppression of reproductive 
parameters and might induce pronounced potential toxicity in some 
estrogen-independent organs in both female and male rats. However, no clear 
influence on reproductive processes could be verified. It must be considered that the 
overall doses of daily isoflavone administered should not exceed by more than 
100-fold of the estimated human consumption reported in Japanese population (3 mg / 
kg / day) (Record et al., 1997). 
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Chapter 5 
Possible Developmental and Reproductive Toxicity of 
Gegen Isoflavones on SD Rats 
5.1 Introduction 
Estrogen-like isoflavones are present not only in soybean but also in other plants. 
It should be noted that potential benefits and adverse effects have to be balanced in 
use of plant extracts in treatment of some disease. One of the examples was that 
consumption of certain plants and plant products can result in impaired reproductive 
function in livestock. Over six decades ago, clover disease, a syndrome with effects 
ranging from temporary to permanent infertility, was described in sheep foraging 
upon subterranean clover in Western Australia (Bennets et al., 1946). Additional 
studies have documented the impaired reproductive function in a number of species, 
including desert quail feeding upon desert brush (Price et al； 1985; Leopold et al., 
1976). Furthermore, a decrease in reproductive performance was also observed in 
female rats fed either a soy-based diet or a diet supplemented with genistin at 2g/kg 
diet, and in male mice fed genistin at 36 mg/mouse/d (Carter et al., 1955; Matrone et 




Isoflavones in soy and clove had already recognized for their estrogenic-like 
effect for a long time. Recently, more attention has been paid on the estrogenic effect 
of the isoflavones to treat and prevent estrogen recessive related diseases in Western 
countries. In fact, isoflavones in soybean is just about 0.1%, while isoflavones in 
Gegen, the dried root of Pueraria lobata or Pueraria thomsonii adopted in China as a 
traditional Chinese medicine, account for 10%, in which the chemical structure of 
puerarin had been proved similar to that of soybean isoflavones, but until now the 





This study investigated whether and how exposure of neonatal rats to Gegen 
isoflavones altered pubertal reproductive development and other growth parameters. 
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5.3 Materials and Methods 
5.3.1 Animals and Diets 
All SD rats (n = 100’ 50 females 4 wks; and 50 males, 4 wks) were divided into 
five groups and fed a standard cereal-based chow diet (PicoLab® Rodent Diet 20 -
Lab Diet, Australia), respectively, as previously described in chapter 4. The 
experimental groups were gavaged with 30，150, 300 and 600 mg Gegen isoflavones 
per kg body weight per day, while the control group was gavaged with the same 
volume of water. 
Gegen Isoflavones with 60% purity was purchased from ShanXi TianRun Phyto 
Co.,Ltd. (ShanXi, China), containing 30.87% puerarin, 1.45% daidzin and 0.71% 
daidzein. The composition of purchased Gegen isoflavones was verified using HPLC 
as described in chapter 2 (2.3.2) (Fig 5.1). 
5.3.2 Study Design 
The study design and the measurement of experimental parameters were as 
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Figure 5.1 HPLC profiles of isoflavone compounds in Gegen isoflavone extracts 
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5.4 Results 
5.4.1 Food Consumption and Food Efficiency Ratio 
Food consumption and food efficiency ratio were measured as previously 
defined in chapter 3 (3.4.1). No difference in food consumption was observed among 
the five groups of female rats，while food efficiency ratio was significantly reduced 
with the increasing dosages of Gegen isoflavones (Table 5.1). Except for the dose 
group of 300 mg isoflavones/kg BW with a lower level of food consumption, there 
was no difference in food consumption among the other experimental groups in male 
rats. There was a dose-dependent decrease in food efficiency ratio with the increasing 
































































































































































































































































5.4.2 Growth Trend 
Significant growth suppression was observed in female rats with orally 
administration of 600 mg Gegen isoflavones/kg BW compared with that of the 
control from the week 2 of study. At week 3 and 4, body weight gain of female rats 
orally given 150 and 300 mg isoflavones/kg BW also began to show a significant 
lower level, respectively, compared with the control group (Table 5.2 and Fig 5.2). 
Similarly, growth depression was first seen in the group of 600 mg Gegen 
isoflavones/kg BW in male rats at week 3，compared with the control, and the dose 
groups of 30 and 150 mg isoflavones/kg BW. At week 4，the dose groups of 150 and 
300 mg isoflavones/kg BW began to show a significant retardation in body weight 
gain compared with the control rats (Table 5.2 and Fig 5.2). In general, the body 
weight gain was inversely related to the dose of Gegen isoflavones given to both 
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Figure 5.2 Changes in body weight growth trends in rats fed the chow diet with oral 
administration of 0, 30, 150, 300, 600 mg Gegen isoflavones per kg body weight. 
Data were expressed as mean 土 SD, n =10. 
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5.4.3 Organ Weights 
5.4.3,1 Absolute Organ Weights 
Significantly decreases in absolute weights of heart, kidney, liver, spleen and 
ovary were seen in the dose groups of 150，300，600 mg isoflavones/kg BW compared 
with that of the control group in female rats. In contrast, oral administration of Gegen 
isoflavones had slight effect to reduce the weight of uterus (Table 5.3). 
In male rats, similar changes were observed after oral administration of Gegen 
isoflavones for three months. In addition, Gegen isoflavones led to larger liver and 
smaller testis, epididymis, prostate and seminal vesicle in rats (Table 5.3). 
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5.4.3 Organ Weights 
5.4.3.1 Absolute Organ Weights 
Significantly decreases in absolute weights of heart, kidney, liver, spleen and 
ovary were seen in the dose groups of 150, 300, 600 mg isoflavones/kg BW compared 
with that of the control group in female rats. In contrast, oral administration of Gegen 
isoflavones had slight effect to reduce the weight of uterus (Table 5.3). 
In male rats, similar changes were observed after oral administration of Gegen 
isoflavones for three months. In addition, Gegen isoflavones led to larger liver and 
smaller testis, epididymis, prostate and seminal vesicle in rats (Table 5.3). 
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5.4.3,2 Relative Organ Weight 
The female rats had significant larger relative liver and spleen when they were 
orally given 300 or 600 mg Gegen isoflavones than those of the control and other dose 
groups. In contrast, oral administration of Gegen isoflavones appealed to have the 
slight effect to increase the relative weights of heart and uterus (Table 5.5). The 
relative liver weight increased significantly in the dose group of 600 mg 
isoflavones/kg BW compared with the control group in male rats. For the reproductive 
organs, the relative testis and epididymis weighted heavier in the dose groups of 300 
and 600 mg isoflavones/kg BW than that of the control group (Table 5.4). 
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Table 5.4 Relative organ weight (organ weight (g)/100 g body weight) in rats fed the 
chow diet with oral administration of 0，30，150，300，600 mg per kg body weight. 
Gegen Isoflavones (mg/kg body weight) 
Control 30 150 300 600 
Female 
Heart 0.34 土 0.03 0.33 土 0.03 0.34 土 0.03 0.35 土 0.03 0.35 土 0.04 
Kidney 0.77 土 0.02ab 0.74 土 0.06b o.73 土 0.06b 0.76 土 0.05ab 0.79 土 0.06' 
Liver 3.07 土 0.22b 2.95 土 0.24b 3.04 土 0.15b 3.29 ±0.24" 3.30 土 0.16" 
Spleen 0.15±0.0lb 0.15 土 O.Olbe 0.16 土 0.17 ±0.022� o.l7 土 0.03a 
Uterus 0.22 土 0.03 0.20 土 0.04 0.21 土 0.07 0.22 土 0.07 0.25 ±0.07 
Ovary 0.04 土 0.01 0.03 ±0.01 0.04 土 0.01 0.04 ±0.01 0.04 土 0.01 
Male 
Heart 0.27 土 0.02 0.27 土 0.02 0.28 土 0.02 0.28 土 0.02 0.29 土 0.03 
Kidney 0.68 土 0.04b o.70± 0.04b o.75± 0.05a o.73 土 0.02b o.78±0.06ab 
Liver 3.25 ±0.14*^ 3.12 土 0.34b 3.33 土 o.2iab 3.47 土 0.29ae 3.54 ± 0.33a 
Spleen 1.83 土 0.09b 1.88 土 0.16b 2.14 土 0.23a 1.90 土 0.17b 1.96 土 o.24ab 
Testis 0.68 土 0.05be 0.63 土 0.04b o.72 土 O.OSa� 0.77 土 0.05a 0.76 ± 0.07a 
Prostate 0.14 土 0.02 0.14 土 0.02 0.14 土 0.03 0.15 土 0.03 0.13 土 0.02 
Epididymis 0.25 土 0.03b o.24±O.Olb o.29± 0.03a 0 29 土 0.0” 0.30 土 0.02a 
Seminal Vesicle 0.15 ±0.04 0.15 土 0.03 0.17 土 0.02 0.16 土 0.03 0.15 土 0.02 
Data were expressed as mean 土 SD，n =10; Means at the same raw with different 
superscript letters (a, b, c) differ significantly a t P < 0.05. 
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5.4.4 Reproductive Hormone Levels 
The concentrations of estradiol and progesterone were measured in the female 
rats at week 6 and 12，respectively. There was no difference in serum progesterone 
concentration among the five groups at week 6, while all groups orally given Gegen 
isoflavones had serum estradiol lower than that of the control group (Table 5.5). At 
week 12, no any significant difference in serum estradiol and progesterone could be 
observed among the control and the Gegen isoflavone groups (Table 5.5). 
The serum testosterone concentration was also analyzed in the male rats, at week 
6 and week 12，respectively. In general, oral administration of Gegen isoflavones led 
to a lower level of testosterone in the early time of the study, but the decrease 
observed was not always statistically significant, at the end of the study, the levels of 
testosterone in all dose groups except the group of 30 mg isoflavones/BW were 








































































































































































































































































































































5.4.5 Epididymis Parameters of Male Rats 
Epididymis lengths were shorter significantly and sperm numbers in epididymis 
were also statistically decreased in the dose groups of 300 and 600 mg isoflavones/kg 





































































































































































































































It was noteworthy to point out that phytoestrogen-free diets were not used in the 
present study. Casanova et al. (1999) demonstrated that it is not necessary to replace diet 
containing phytoestrogens with phytoestrogen-free diet in most developmental toxicology 
studies. However, phytoestrogen-free diets are recommended to be used in endocrine 
toxicology studies at low doses to determine the effects of chemicals on reproduction. In 
the present study, fairly high doses of phytoestrogens were applied to rats, therefore 
phytoestrogen-free diets were not used. 
After weaning, body weight gain of both females and males depend significantly on 
the diet. Indication of toxicity of Gegen isoflavone extracts might be found in the growth 
suppression seen in rats of both genders administered with relatively higher doses (150， 
300 and 600 mg Gegen isoflavones / kg body weight). The present results of Gegen 
isoflavones were consistent with the effects of soybean isoflavones discussed in the 
chapter 4, suggesting the isoflavones derived from Gegen might have stronger inhibitory 
effects on the growth of rats. 
The present study demonstrated that relative kidney weights were significantly 
increased in both male and female rats given 600 mg isoflavones/kg BW. Phytoestrogens 
have been reported to have beneficial effects on kidney function (Velasquez et al., 2001). 
While in some feeding studies of rats, dietary genistein at > 250 ^ig/g feed induced a 
significant increase in the incidence and / or severity of nephrocalcinosis, or 
mineralization of the renal tubules, which could cause an increased kidney weight in both 
sexes (Delclos et al., 2001). This is a sex-related lesion common in untreated female rats 
and influenced by diet composition (Ritskes-Hoitinga et a!.，1992). Evidence on toxicity 
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of the Gegen extracts to the liver was also paralleled to the previous results in the study 
that soybean isoflavones would cause the increased relative liver weight in rats of both 
genders, suggesting that Gegen isoflavones might have the hepatotoxicity as well. 
The present study also found that Gegen isoflavone could increase relative uterus 
weights in the dose group of 600mg isoflavones/kg BW, though there was no significant 
difference. The results were different from the effects of soybean isoflavones previously 
discussed. However, phytoestrogens have long been recognized for their uterotrophic 
activity in a variety of animal species. These effects range from temporary to permanent 
infertility (Adams, 1989). In another previous study, there was a dose-dependent increase 
in relative uterine weight with effects seen at a dietary dose of genistein as low as 375 
jj-g/g diet, which was consistent with the present results, suggesting that genistein acts in 
the uterus in a manner similar to that of estradiol. That is, genistein binds to the estrogen 
receptor (ER), and the ligand: receptor complex induces the expression of 
estrogen-responsive genes, which ultimately result in increased uterine mass (Ross et al.’ 
1997). 
In several species, adequate levels of progesterone are required for normal 
decidualization, inhibition of progesterone synthesis or a blockade of receptor binding 
will result in failure of blastocyst implantation and interruption of early pregnancy (Ghost 
et al, 1997). In the present study, serum levels of progesterone were decreased in the four 
treatment groups compared with the control group, though the differences were not 
significant, while the estradiol concentration in the group given 30，150 and 300 mg 
Gegen isoflavones/kg body weight was lower compared with the control group. The 
results could further confirm the study of Qi et al. (2002), who demonstrated that 
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estradiol level was decreased slightly in SD rats after being gastrogavaged with Gegen 
isoflavones for thirty days, suggesting the Gegen isoflavones could influence the total 
estrogen levels in rats. The difference in the extent to change the sex hormone levels in 
the results of two studies may due to the dose and exposure period to the Gegen 
isoflavones. 
Although the study regarding the effects of phytoestrogens on females continues to 
be an important research concern, there has been an increasing concern of the effect of 
exogenous estrogens on male reproductive physiology. The prostate is of considerable 
interest because it is a major site of morbidity and mortality in men. The soy consumption 
was inversely associated with lower risk of development of advanced prostate cancer in 
epidemiologic studies. Several studies involving developmental exposure to 
phytoestrogens have shown effects on the prostate, although clear-cut conclusions on the 
effects of developmental exposures to phytoestrogens on the prostate are not yet possible. 
In the present study, Gegen isoflavones had shown no effect on prostate weight, which 
might be explained by the conclusions of the previous study that neonates were much less 
sensitive than adults to the estrogen-like actions of genistein in males (Strauss et al.’ 
1998). 
Another focus of attention was related to the increasing interest in the role of 
estrogens in spermatogenesis and the hypothesis that environmental estrogen exposure 
may lead to decreased sperm counts and increased testis weight. The present study found 
both decreased sperm counts and increased testis weight in the dose groups orally given 
300 and 600 mg Gegen isoflavones/kg BW. 
In theory, exposure to high concentrations of any exogenous estrogen could cause 
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alterations in gonadotrophin levels and in the function of the reproductive system. Recent 
reports suggest that “environmental estrogens" may be responsible for the apparent 
decline in semen quality (Sharpe, 1993). If such a link in male fertility exists, the 
fetal-prepubertal period and Sertoli cell development would be of critical importance 
(Sharpe et al, 1993; Sharpe, 1993). Plant phytoestrogens are a class of "environmental 
estrogens", with some compounds, including genistein and daidzein, having significant 
hormonal potency in in vitro systems (Miksicek, 1995). In male rats, neonatal exposure to 
genistein reduced LH secretion and plasma testosterone concentrations in adulthood 
(Faber et al” 1991)，which was consistent with the present results at week 6，while at 
week 12, the testosterone level in the male rats administered with 150 and 300 mg Gegen 
isoflavones/kg body weight was abnormally higher than the other rats, but the causation 
could not be explained at the existing condition in the present study. The data of the 
present researches available to this point show equivocal evidence for the effect of 
developmental exposure to phytoestrogens on spermatogenesis, and adverse reproductive 
outcomes or other long-term testicular toxicity have not been demonstrated (Sharpe and 
Skakkebaek, 1993; Whitten and Naftolin, 1992). 
In summary, the present study provided the evidence that Gegen isoflavones might 
exert adverse effects in development of rats. The results suggested that the inhibitory 
effects of Gegen isoflavones to development might not due to sex hormone disorders but 
to the reduction of food efficiency ratio and other mechanisms unknown. However, the 
magnitude and direction of the responses are dependent on the compounds, the dose, the 
timing of the dose, and the exposure period to the phytoestrogens. Many, but not all of 
the observed effects in the present study are consistent with other reported results and 
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conclusions. Although in some cases the result of phytoestrogen exposure is clearly 
beneficial or adverse, in other cases, the consequences are not clear and require long-term 
study. 
The phytoestrogens are potentially important weapons in the battle against a range 
of human diseases, but it is also important to determine in targeted and carefully 
controlled human studies whether potentially adverse effects in developmental and adult 





The present study was carried out to study the positive and negative health effects of 
isoflavones derived from the two plants, soybean and Gegen. In the present study, 
isoflavones and their glycosides from soybean and Gegen were isolated and identified. 
The eight compounds in soybean isoflavones were determined as daidzin, glycitin, 
genistin, 6"-0-malonyldaidzin, 6"-0-malonylglycitin, 6"-0-malonylgenistin, daidzein, 
and genistein. The known Isoflavone components in Gegen were identified as 
3"-hydroxy 1-puerarin, puerarin, daidzin, genistin, daidzein, and genistein. 
One of the mechanisms to prevent cardiovascular disease and reduce atherosclerosis 
is to improve the serum lipid concentration. The ratio of non-HDL to HDL is usually used 
as a risk factor of cardiovascular disease, the higher the ratio, the greater the risk of 
cardiovascular disease. By using hamsters of both genders as animal models, soybean 
isoflavones could significantly reduce the serum TC, non-HDL-C, and TG, and also 
modulate the ratios of HDL-C to TC and non-HDL-C to HDL-C effectively in 
ovariectomized, castrated, and intact male hamsters fed a high cholesterol diet. While 
Gegen isoflavones could also favorably improve the serum lipoprotein profiles in the 
three treated hamsters. The results strongly suggested the hypocholesterolemic activities 
of soybean and Gegen isoflavone extracts were at least partially attributable to their 
estrogenic actions, while there may exist other unknown mechanism to explain the 




Act as antagonist, phytoestrogens may have adverse effects on the reproductive 
health and development. The present study demonstrated clearly that both isoflavones 
derived from soybean and Gegen could retard the growth in immature rats of both 
genders with dose-response relationship. In addition, soybean isoflavones had 
pronounced influence to suppress estradiol and progesterone levels in female and 
testosterone level in male rats, and might greatly decrease the relative uterus weight in 
female rats and sperm counts in male rats when the rats were consuming a relatively high 
dose. While the effects of Gegen isoflavones to affect the sex hormone concentrations in 
both genders of rats were not evident as that of soybean isoflavones, a high dose of 
Gegen isoflavones could also decrease the sperm counts in male rats. The present study 
showed that isoflavones in soybean and Gegen might have different target sites to exert 
development and reproductive toxicity. 
In conclusion, phytoestrogens are common in the human diet and able to exert many 
biological effects that have been observed in in vivo and in vitro, as well as in 
epidemiological researches. Although many of these effects are considered as positive to 
human health, the adverse effects have also been shown. Therefore, investigations are 
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